[go: up one dir, main page]

CN100584292C - Artificial heart stent valve - Google Patents

Artificial heart stent valve Download PDF

Info

Publication number
CN100584292C
CN100584292C CN200510110145A CN200510110145A CN100584292C CN 100584292 C CN100584292 C CN 100584292C CN 200510110145 A CN200510110145 A CN 200510110145A CN 200510110145 A CN200510110145 A CN 200510110145A CN 100584292 C CN100584292 C CN 100584292C
Authority
CN
China
Prior art keywords
stent
valve
mesh
artificial heart
middle section
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN200510110145A
Other languages
Chinese (zh)
Other versions
CN1961845A (en
Inventor
温宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Balance Medical Technology Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200510110145A priority Critical patent/CN100584292C/en
Publication of CN1961845A publication Critical patent/CN1961845A/en
Application granted granted Critical
Publication of CN100584292C publication Critical patent/CN100584292C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

本发明提供了一种人工心脏支架瓣膜。该支架瓣膜包括管形网状支架、瓣膜叶、密封膜、不透X线标志和柔性联结环。其中的网状支架的中段可为圆管形或鼓形,或设有径向突出结构,或设有外层环状结构,或设有外层游离舌,或设有径向突出结构加外层游离舌。本发明的支架瓣膜形状、结构和功能更优化;可径向压缩在介入装置帮助下准确输送到位,然后扩张,扩张释放后的人工支架瓣膜在径向和轴向符合血管壁形状,不会产生瓣周漏;植入后可发挥正常瓣膜的作用,可防止在血液返流瓣膜关闭时,反方向血液造成人工瓣膜滑动。

Figure 200510110145

The invention provides an artificial heart stent valve. The stent-valve includes a tubular mesh stent, valve leaflets, a sealing membrane, radiopaque markers and a flexible coupling ring. The middle section of the mesh stent can be in the shape of a round tube or a drum, or be provided with a radially protruding structure, or be provided with an outer annular structure, or be provided with an outer free tongue, or be provided with a radially protruding structure plus an outer ring structure. Layer free tongue. The shape, structure and function of the stent valve of the present invention are more optimized; it can be radially compressed and accurately transported in place with the help of an interventional device, and then expanded. After expansion, the artificial stent valve conforms to the shape of the blood vessel wall in the radial and axial directions, without Paravalvular leakage: After implantation, it can play the role of a normal valve, which can prevent the artificial valve from slipping due to reverse blood flow when the valve is closed.

Figure 200510110145

Description

人工心脏支架瓣膜 Artificial heart stent valve

技术领域 technical field

本发明涉及一种人体组织的替代品,尤其涉及一种人工心脏支架瓣膜。The invention relates to a substitute for human tissue, in particular to an artificial heart stent valve.

背景技术 Background technique

心脏是人体最重要的器官,心脏分为左右两部分,每一部分又包括心房和心室。左右心房和左右心室分别由房间隔和室间隔分开。在心脏内存在四个心脏瓣膜,即三尖瓣、肺动脉瓣、二尖瓣和主动脉瓣。在人体血液循环机构中,四个心脏瓣膜起着至关重要的作用。体循环机构的缺氧血液经腔静脉进入右心房,然后通过三尖瓣进入右心室,右心室收缩将血液通过肺动脉瓣压入肺循环机构,经过肺氧饱和后的血液经肺静脉回到左心房,再经二尖瓣到达左心室,左心室收缩将血液通过主动脉瓣排入主动脉而重返体循环机构。主动脉瓣膜下有左右冠状动脉开口。四个心脏瓣膜的结构保证了血液顺方向时瓣膜开放,逆方向时关闭,防止了血液返流而引起的心脏负担加重。但由于各种原因,会导致心脏瓣膜的后天性损伤或病变,如风湿,动脉粥样硬化等。此外,先天性心脏病如法乐氏四联症,术后远期也可产生肺动脉瓣膜病变。瓣膜病变后表现为瓣膜功能逐渐丧失,如瓣膜关闭不全导致血液返流,瓣膜狭窄导致血液流通不畅,或关闭不全和狭窄二者兼并,以至加重心脏负担,导致心脏功能衰竭。对于心脏瓣膜的后天性损伤或病变,传统的治疗方法是开胸,心脏停跳后,在低温体外循环支持下,打开心脏进行病变瓣膜的外科修复或用人工心脏瓣膜置换。现有的人工心脏瓣膜分两大类:金属机械瓣膜和生物瓣膜。生物瓣膜由牛心包、牛颈静脉瓣、猪主动脉瓣等动物材料处理后制成。上述开心手术的方法,手术时间长,费用高,创伤大,风险大,金属机械瓣膜置换后病人需要长期抗凝治疗,生物瓣膜的材料寿命有限,通常需要再手术。The heart is the most important organ of the human body. The heart is divided into two parts, the left and the right, and each part includes the atrium and the ventricle. The left and right atria and right and left ventricles are separated by the atrial and ventricular septum, respectively. There are four heart valves in the heart, namely the tricuspid valve, pulmonary valve, mitral valve and aortic valve. In the human blood circulation mechanism, the four heart valves play a vital role. The hypoxic blood from the systemic circulation mechanism enters the right atrium through the vena cava, and then enters the right ventricle through the tricuspid valve. The contraction of the right ventricle pushes the blood into the pulmonary circulation mechanism through the pulmonary valve, and the oxygen-saturated blood returns to the left atrium through the pulmonary vein, and then Through the mitral valve to the left ventricle, the left ventricle contracts to expel blood through the aortic valve into the aorta and return to the systemic circulation. There are left and right coronary artery openings under the aortic valve. The structure of the four heart valves ensures that the valves open when the blood flows in the forward direction and close when the blood flows in the opposite direction, preventing the heart from increasing the burden caused by the backflow of blood. However, due to various reasons, acquired damage or pathology of heart valves can be caused, such as rheumatism, atherosclerosis, etc. In addition, congenital heart disease such as tetralogy of Fallot can also cause pulmonary valve disease in the long term after surgery. After valvular disease, the valve function is gradually lost, such as valvular insufficiency leading to blood regurgitation, valvular stenosis leading to poor blood flow, or both insufficiency and stenosis, which will increase the burden on the heart and lead to heart failure. For the acquired damage or disease of the heart valve, the traditional treatment method is to open the chest, and after the heart stops beating, the heart is opened to perform surgical repair of the diseased valve or replace it with an artificial heart valve under the support of hypothermic extracorporeal circulation. The existing artificial heart valves are divided into two categories: metal mechanical valves and biological valves. Biological valves are made from processed animal materials such as bovine pericardium, bovine jugular valve, and porcine aortic valve. The above-mentioned open-heart surgery method has long operation time, high cost, large trauma, and high risk. After metal mechanical valve replacement, the patient needs long-term anticoagulant treatment, and the material life of the biological valve is limited, and reoperation is usually required.

为了解决上述开心手术治疗心脏瓣膜存在的问题,现在已有人尝试不作开心手术,而采用经皮介入方法输放人工心脏瓣膜。现有技术的介入式人工心脏瓣膜有二种:In order to solve the above-mentioned problems of open-heart surgery for the treatment of heart valves, some people try not to perform open-heart surgery, but use percutaneous intervention to deliver artificial heart valves. The interventional artificial heart valve of prior art has two kinds:

1、球囊扩张型1. Balloon-expandable

这种球囊扩张型人工心脏瓣膜为生物瓣膜,其介入方法是在一个可塑性变形的支架上分别固定生物瓣膜,通过径向压缩在一个球囊上后直径变小,经皮输放,然后给球囊加压使支架扩张固定,达到工作状态。This balloon-expandable artificial heart valve is a biological valve. The intervention method is to respectively fix the biological valve on a plastically deformable stent, radially compress it on a balloon, and then reduce the diameter, deliver it percutaneously, and then give it to the patient. The balloon is pressurized to expand and fix the stent to reach the working state.

1989年Henning Rud ANDERSEN(专利号WO9117720)率先进行了猪主动脉瓣经导管人工心脏瓣膜置换(文献…European Heart Journal 1992 13,704-708)。In 1989, Henning Rud ANDERSEN (Patent No. WO9117720) took the lead in carrying out porcine aortic valve transcatheter artificial heart valve replacement (document... European Heart Journal 1992 13, 704-708).

2000年Philippe BONHOEFFER(专利号EP 1057460)和Alain CRIBIER2000 Philippe BONHOEFFER (Patent No. EP 1057460) and Alain CRIBIER

(专利号EP0967939)分别首次进行了在人体的经导管介入的肺动脉瓣膜和主动脉瓣膜的人工心脏瓣膜置换。(Patent No. EP0967939) performed the artificial heart valve replacement of the pulmonary valve and the aortic valve in the human body for the first time.

球囊扩张型人工瓣膜存在的缺点和问题是:其直径由球囊直径所决定,如果人工瓣膜的直径一开始没选择好,或某些生理变化后,如自然生长、病理性血管扩张等,自然瓣膜的口径大小可能增大,而人工瓣膜的口径不能适应性增大,人工瓣膜有松动或滑脱的危险,只能进行二次球囊再扩张。The disadvantages and problems of the balloon-expandable artificial valve are: its diameter is determined by the diameter of the balloon. If the diameter of the artificial valve is not selected at the beginning, or after some physiological changes, such as natural growth, pathological vascular expansion, etc., The caliber of the natural valve may increase, but the caliber of the artificial valve cannot be adaptively increased, and the artificial valve may loosen or slip off, so only secondary balloon re-expansion can be performed.

2、自扩张型2. Self-expanding

这种人工瓣膜设有一个弹性变形支架,径向压缩后可自行扩张。This prosthetic valve features an elastically deformable stent that expands on its own after being radially compressed.

Marc BESSLER(专利号US5855601)和Jacques SEGUIN(专利号FR2826863,FR2828091)也设计了经导管人工心脏瓣膜置换。不同的是他们用了一个可弹性变形支架,径向压缩后可自行扩张。Marc BESSLER (Patent No. US5855601) and Jacques SEGUIN (Patent No. FR2826863, FR2828091) also designed transcatheter prosthetic heart valve replacement. The difference is that they used an elastically deformable stent that can expand by itself after radial compression.

Philippe BONHOEFFER(专利号EP1281375,US2003036791)的人工心脏瓣膜利用一个可弹性变形支架,在支架上游端或远端装有触头,压在内外两个鞘管内。The artificial heart valve of Philippe BONHOEFFER (patent No. EP1281375, US2003036791) utilizes an elastically deformable stent, and contacts are housed at the upstream end or the distal end of the stent, and are pressed in the two inner and outer sheath tubes.

本申请人曾在中国发明专利申请号200410054347.0的发明申请中使用了中段为鼓型的支架瓣膜和自扩型加强化合成支架瓣膜,及捆绑式输放装置。The applicant once used a drum-shaped stent valve in the middle section, a self-expanding reinforced synthetic stent valve, and a bundled delivery device in the invention application of China Invention Patent Application No. 200410054347.0.

自扩张型人工瓣膜存在的缺点和问题是:自扩张型人工心脏瓣膜与鞘管间摩擦力大,影响人工瓣膜准确释放。The disadvantages and problems of the self-expandable artificial heart valve are: the frictional force between the self-expandable artificial heart valve and the sheath tube is large, which affects the accurate release of the artificial valve.

捆绑式输放装置的支架拉线,穿过人工瓣膜的可变形单元时摩擦力大,不穿过时拉线易脱位。The support wire of the bundled delivery device has a large friction force when passing through the deformable unit of the artificial valve, and the wire is easy to dislocate when not passing through.

上述球囊扩张型和自扩张型人工心脏瓣膜存在的共同缺点和问题是:The common shortcoming and the problem that above-mentioned balloon expansion type and self-expanding artificial heart valve exist are:

1、现有的介入式人工支架瓣膜的输放装置和径向压缩下的支架瓣膜较硬,弯曲性差,经过主动脉弓不容易,不能对准自然主动脉瓣膜口。1. The delivery device of the existing interventional artificial stent valve and the stent valve under radial compression are relatively hard and poor in flexibility. It is not easy to pass through the aortic arch and cannot be aligned with the natural aortic valve orifice.

2、即便在x光透视帮助下,介入式人工支架瓣膜和它的输放装置的轴向上下游定位也因对解剖位置的判断不准和血流冲击下的人工瓣膜不稳定而变得不容易。介入式人工主动脉瓣膜如果位置偏上游可影响二尖瓣,如果位置偏下游可堵阻冠状动脉开口。2. Even with the help of X-ray fluoroscopy, the axial upstream and downstream positioning of the interventional artificial stent valve and its delivery device becomes uncertain due to the inaccurate judgment of the anatomical position and the instability of the artificial valve under the impact of blood flow. easy. The interventional prosthetic aortic valve can affect the mitral valve if it is positioned upstream, and it can block the coronary artery opening if it is positioned downstream.

3、介入式主动脉瓣人工支架瓣膜和它的输放装置的旋转方向定位没能解决。介入式人工主动脉瓣膜如果旋转位置不对可堵阻冠状动脉开口。3. The rotation direction positioning of the interventional aortic valve artificial stent valve and its delivery device cannot be solved. The interventional prosthetic aortic valve can block the opening of the coronary artery if it is rotated incorrectly.

4、自扩型人工支架瓣膜高度压缩下,鞘管的回退会遇到很大的阻力。退鞘管的阻力和困难还会使操作者将已定好位的人工支架瓣膜移位。4. When the self-expanding artificial stent valve is highly compressed, the retraction of the sheath will encounter great resistance. The resistance and difficulty of withdrawing the sheath can also cause the operator to displace the fixed artificial stent valve.

5、在释放过程中,支架瓣膜逐渐半扩张到全扩张,所需时间超过一个心跳周期。扩张的支架瓣膜会阻碍血流,支架瓣膜也可因血流冲击而使其位置改变。特别是球囊扩张型人工支架瓣膜在球囊扩张过程中完全阻断血流。5. During the release process, the stent valve gradually expands from half to full expansion, and the required time exceeds one heartbeat cycle. The expanded stent valve can obstruct blood flow, and the stent valve can also change its position due to the impact of blood flow. In particular, balloon-expandable prosthetic stent-valves completely block blood flow during balloon expansion.

6、如果病人已有冠状动脉搭桥(Coronary Artery Bypass),已植入的人工支架瓣膜不应该在升主动脉处影响搭桥开口的血液灌流。6. If the patient has coronary artery bypass (Coronary Artery Bypass), the implanted artificial stent valve should not affect the blood perfusion of the bypass opening at the ascending aorta.

7、Jacques SEGUIN和Philippe BONHOEFFER的主动脉瓣自扩型支架瓣膜如能成功植入,虽然术后不会马上影响冠状动脉的灌流,但是支架中部在主动脉根部不贴血管壁,让血流从支架网眼中流过,一方面会有血栓形成的可能;另一方面会影响或妨碍未来可能的冠状动脉介入诊断和治疗。7. If the aortic valve self-expanding stent valve of Jacques SEGUIN and Philippe BONHOEFFER can be successfully implanted, although the perfusion of the coronary artery will not be affected immediately after the operation, the middle part of the stent will not stick to the vessel wall at the aortic root, so that the blood flow Flow through the stent mesh, on the one hand, may cause thrombus formation; on the other hand, it will affect or hinder possible future diagnosis and treatment of coronary artery intervention.

8、释放扩张后的支架瓣膜的固定也存在以下问题:8. There are also the following problems in the fixation of the stent valve after release and expansion:

a)收缩期和舒张期血流冲击会使固定不好的人工支架瓣膜移动。a) The impact of blood flow during systole and diastole will move the poorly fixed artificial stent valve.

b)有些主动脉瓣关闭不全的病人其主动脉根部术前已有病理性扩张,需b) Some patients with aortic valve insufficiency have pathological expansion of the aortic root before surgery, and need to

要很大的支架瓣膜才能与其吻合固定。It takes a very large stent valve to anastomose and fix it.

c)有些病人在人工支架瓣膜植入后局部会有解剖性变化,如扩张,使不c) Some patients will have local anatomical changes after artificial stent valve implantation, such as expansion, so that the

能相应变化的支架瓣膜失去有效固定。The stent valve that can change accordingly loses effective fixation.

9、扩张固定后的人工支架瓣膜在很多情况下有瓣周漏(Para valvularleaks),即血液从支架瓣膜和血管壁之间漏过。9. The artificial stent valve after expansion and fixation has paravalvular leaks (Para valvular leaks) in many cases, that is, blood leaks between the stent valve and the vessel wall.

10、瓣膜叶开关中如果接触到金属支架,会造成瓣膜叶磨损。10. If the valve leaflet switch touches the metal bracket, the valve leaflet will be worn.

11、如果为了固定好而采用大直径支架瓣膜,瓣叶联合点(Commissure)会承受很大应力,造成瓣膜叶联合点撕损。11. If a large-diameter stent valve is used for fixation, the commissure of the valve leaflets will bear a lot of stress, resulting in tearing of the commissure of the valve leaflets.

发明内容 Contents of the invention

本发明的目的,在于克服现有技术存在的上述问题,提供一种新型结构的人工心脏支架瓣膜。既可用于介入式治疗,也可用于微创手术治疗。The purpose of the present invention is to overcome the above-mentioned problems that prior art exists, and a kind of artificial heart stent valve of novel structure is provided. It can be used for both interventional therapy and minimally invasive surgery.

本发明的目的是这样实现的:一种人工心脏支架瓣膜,其特点是,包括一个可以在扩张状态和压缩状态之间径向变形的管形网状支架,该网状支架包括上游段、中段和下游段,网状支架各网线之间构成或围成多个可变形单元,在网状支架的两端形成多个开放式线拐,并设有与可变形单元分开的密封式线眼,在网状支架中段的内侧连接有可以开关并让血液单向通过的瓣膜叶,瓣膜叶与网状支架相结合处构成瓣叶联合线,二个相邻的瓣膜叶的瓣叶联合线相交构成瓣叶联合点,在网状支架上游段的内侧和/或外侧面上覆盖有密封膜并延伸至中段,在网状支架上设有多个不透X线标志和柔性联结环。The object of the present invention is achieved like this: a kind of artificial heart stent valve is characterized in that, comprises a tubular mesh support that can be radially deformed between expanded state and compressed state, and this mesh support comprises upstream section, middle section and the downstream section, a plurality of deformable units are formed or enclosed between the network wires of the mesh support, and a plurality of open wire bends are formed at both ends of the mesh support, and a sealed line eye separate from the deformable unit is provided. On the inner side of the middle section of the mesh stent, there are valve leaflets that can be switched on and off and allow blood to pass through in one direction. The junction of the valve leaflets and the mesh stent forms the leaflet joint line, and the joint line of the two adjacent valve leaflets intersects to form The leaflet juncture is covered with a sealing film on the inner and/or outer sides of the upstream section of the mesh stent and extends to the middle section, and a plurality of radiopaque signs and flexible coupling rings are arranged on the mesh stent.

上述人工心脏支架瓣膜,其中,所述的网状支架可以由弹性线材编织而成,也可以由弹性管材切割而成。In the aforementioned artificial heart stent valve, the mesh stent may be woven from elastic wires or cut from elastic tubes.

上述人工心脏支架瓣膜,其中,所述的网状支架整体呈大小一致的圆管形,在圆管形网状支架的中段设有支架开口。The above-mentioned artificial heart stent valve, wherein, the mesh stent is in the shape of a circular tube with the same size as a whole, and a stent opening is provided in the middle section of the circular tube-shaped mesh stent.

上述人工心脏支架瓣膜,其中,所述的网状支架的中段呈向外突出的鼓形,在鼓形中段的中部设有支架开口。The above-mentioned artificial heart stent valve, wherein, the middle section of the mesh stent is in the shape of a drum protruding outward, and a bracket opening is provided in the middle of the drum-shaped middle section.

上述人工心脏支架瓣膜,其中,所述的网状支架的中段在圆管形或轻微鼓形的基础上变形出至少一个向外突出的径向突出结构,在每个径向突出结构的中心设有一个较大的支架开口,径向突出结构与网状支架本体相连处形成一个半月形的上游周边和一个半月形的下游周边,半月形的上游周边构成与瓣膜叶相连的瓣叶联合线。The above-mentioned artificial heart stent valve, wherein, the middle section of the mesh stent deforms at least one outwardly protruding radial protruding structure on the basis of a circular tube shape or a slight drum shape, and a center of each radial protruding structure is provided. There is a large stent opening, and the connection between the radially protruding structure and the mesh stent body forms a half-moon-shaped upstream periphery and a half-moon-shaped downstream periphery, and the half-moon-shaped upstream periphery forms a leaflet joint line connected with the valve leaflets.

上述人工心脏支架瓣膜,其中,所述的网状支架中段的径向突出结构为一个。In the above-mentioned artificial heart stent valve, there is one radially protruding structure in the middle section of the mesh stent.

上述人工心脏支架瓣膜,其中,所述的网状支架中段的径向突出结构为两个,两个径向突出结构为90-180度转角分配。The above-mentioned artificial heart stent valve, wherein, there are two radially protruding structures in the middle section of the mesh stent, and the two radially protruding structures are distributed at 90-180 degree rotation angles.

上述人工心脏支架瓣膜,其中,所述的网状支架中段的径向突出结构为三个,三个径向突出结构沿径向均匀分配。In the aforementioned artificial heart stent valve, there are three radially protruding structures in the middle section of the mesh stent, and the three radially protruding structures are evenly distributed along the radial direction.

上述人工心脏支架瓣膜,其中,所述的网状支架的上游段呈喇叭形,喇叭形上游段的外缘设有与中段的径向突出结构相对应的波浪形口边。The above-mentioned artificial heart stent valve, wherein, the upstream section of the mesh stent is trumpet-shaped, and the outer edge of the trumpet-shaped upstream section is provided with a wavy lip corresponding to the radially protruding structure of the middle section.

上述人工心脏支架瓣膜,其中,所述的网状支架的中段为圆管形内外双层结构,在支架本体上连接有一个外层环状结构,外层环状结构与内层在下游段或下游段与中段的交界处相连形成固定缘,外层环状结构止于上游段与中段的交界处形成游离缘并可设有密封式线眼与可变形单元分开。The above-mentioned artificial heart stent valve, wherein, the middle section of the mesh stent is a circular tube-shaped inner and outer double-layer structure, and an outer annular structure is connected to the stent body, and the outer annular structure and the inner layer are in the downstream section or The junction of the downstream section and the middle section is connected to form a fixed edge, and the outer annular structure ends at the junction of the upstream section and the middle section to form a free edge and can be provided with a sealed line eye to separate from the deformable unit.

上述人工心脏支架瓣膜,其中,所述的网状支架的中段以圆管形或轻微鼓形为内层,外侧连接有至少一个由单根网线围合而成的游离舌外层,所述的游离舌与内层支架体在下游段或下游段与中段的交界处相连形成固定缘,并从固定缘开始向上游段延伸至上游段与中段的交界处形成游离缘,游离缘前端可设有密封式线眼,线眼上可套有不透X线标志。The above-mentioned artificial heart stent valve, wherein, the middle section of the mesh stent has a circular tube shape or a slight drum shape as the inner layer, and at least one outer layer of the free tongue surrounded by a single mesh wire is connected to the outside. The free tongue and the inner support body are connected at the downstream section or the junction of the downstream section and the middle section to form a fixed edge, and extend from the fixed edge to the upstream section to form a free edge at the junction of the upstream section and the middle section. The front end of the free edge can be provided with Sealed eyelets, which can be covered with X-ray-opaque marks.

上述人工心脏支架瓣膜,其中,所述的游离舌为三个,三个游离舌以120度转角分配,并与瓣膜叶相对应。The above-mentioned artificial heart stent valve, wherein, there are three free tongues, and the three free tongues are allocated at a 120-degree turning angle and correspond to the valve leaflets.

上述人工心脏支架瓣膜,其中,所述的网状支架的中段在圆管形或轻微鼓形的基础上变形出至少一个向外突出的径向突出结构,在各径向突出结构上连接有由单根网线围合而成的游离舌,游离舌的游离缘与径向突出结构的周边至少是半月形的上游周边在两个平行的曲面上重叠。The above-mentioned artificial heart stent valve, wherein, the middle section of the mesh stent deforms at least one outwardly protruding radial protruding structure on the basis of a circular tube shape or a slight drum shape, and each radial protruding structure is connected with a A free tongue enclosed by a single wire, the free edge of the free tongue and the periphery of the radially protruding structure are at least half-moon-shaped upstream periphery overlapping on two parallel curved surfaces.

上述人工心脏支架瓣膜,其中,所述的瓣膜叶可以由生物材料构成,也可以由合成材料构成,在合成材料瓣膜叶内设有至少一条加强纤维,该加强纤维起止于同一瓣膜叶的两个不同的联合点或联合线,连接在网状支架上。The above-mentioned artificial heart stent valve, wherein, the valve leaflets can be made of biomaterials or synthetic materials, and at least one reinforcing fiber is arranged in the valve leaflets of synthetic materials, and the reinforcing fibers start and end at two of the same valve leaflets. Different joint points or joint lines, connected on the mesh support.

上述人工心脏支架瓣膜,其中,所述的加强纤维主要设置在瓣膜叶的下游面,也可以设置在瓣膜叶的游离边或关闭边。In the above-mentioned artificial heart stent valve, the reinforcing fibers are mainly arranged on the downstream surface of the valve leaflet, and may also be arranged on the free edge or closing edge of the valve leaflet.

上述人工心脏支架瓣膜,其中,所述的瓣膜叶为二至三个,三个瓣膜叶呈120度转角分配,每个瓣膜叶包括游离边和关闭边,游离边和关闭边之间形成关闭区。The above-mentioned artificial heart stent valve, wherein, the valve leaflets are two to three, and the three valve leaflets are distributed at a 120-degree angle, and each valve leaflet includes a free edge and a closing edge, and a closing area is formed between the free edge and the closing edge .

上述人工心脏支架瓣膜,其中,所述的密封膜可以由生物材料构成,也可以由合成材料构成,在合成材料密封膜内设有至少一条加强纤维,该加强纤维呈圆周环形布置,并与网状支架相连或联结。The above-mentioned artificial heart stent valve, wherein, the sealing membrane can be made of biological material or synthetic material, and at least one reinforcing fiber is arranged in the sealing membrane of synthetic material, and the reinforcing fiber is arranged in a circular shape, and is connected with the mesh Linked or connected with brackets.

上述人工心脏支架瓣膜,其中,所述的密封膜在网状支架的密封式线眼处相应设有内外相通的密封膜眼。The above-mentioned artificial heart stent valve, wherein, the sealing membrane is provided with a sealing membrane eye communicating with the inside and outside at the sealing line eye of the mesh stent.

上述人工心脏支架瓣膜,其中,所述的密封膜可以在网状支架以外向上游方向延伸构成没有支架支承的软膜,可以在网状支架以内向下游方向延伸到瓣叶联合线。The above-mentioned artificial heart stent valve, wherein, the sealing membrane can extend upstream outside the mesh stent to form a soft membrane without stent support, and can extend downstream inside the mesh stent to the leaflet commissure line.

上述人工心脏支架瓣膜,其中,所述加强纤维选自涤纶纤维、丙纶纤维、聚乙烯纤维或碳纤维。The above-mentioned artificial heart stent valve, wherein, the reinforcing fiber is selected from polyester fiber, polypropylene fiber, polyethylene fiber or carbon fiber.

上述人工心脏支架瓣膜,其中,所述的不透X线标志为套装在网线上的管形点状标志,该管形点状标志设置在网状支架中段的瓣叶联合点,也可以设置在网状支架的上游段或上游段与中段的交界处或下游段。The above-mentioned artificial heart stent valve, wherein the radio-opaque mark is a tubular point-shaped mark set on the mesh wire, and the tubular point-shaped mark is set at the valve leaflet joint point in the middle section of the mesh stent, and can also be set at The upstream section of the mesh support or the junction of the upstream section and the middle section or the downstream section.

上述人工心脏支架瓣膜,其中,所述的不透X线标志为头尾相连的线状标志,该线状标志相邻于瓣叶联合线交织在网状支架的网线上。The above-mentioned artificial heart stent valve, wherein, the radio-opaque mark is a linear mark connected head to tail, and the linear mark is adjacent to the joint line of the leaflets and interweaves on the mesh wire of the mesh stent.

上述人工心脏支架瓣膜,其中,所述的柔性联结环设置在网状支架两端的开放式线拐和密封式线眼处以及网状支架的中部。The above-mentioned artificial heart stent valve, wherein, the flexible coupling ring is arranged at the open wire bends and the sealed wire eyes at both ends of the mesh stent and the middle part of the mesh stent.

上述人工心脏支架瓣膜,其中,还包括密封环,该密封环设置在网状支架的上游段与中段交界处的外侧,所述的密封环为柔软的半开放式管状结构,可以呈圆环形或与径向突出结构相对应的波浪形,其上设有多个点状开口朝向支架瓣膜的内面或外面,或设有槽状开口朝向支架瓣膜的内面。The above-mentioned artificial heart stent valve, which also includes a sealing ring, which is arranged on the outside of the junction between the upstream section and the middle section of the mesh stent, and the sealing ring is a soft semi-open tubular structure, which can be circular Or the wave shape corresponding to the radially protruding structure is provided with a plurality of point-shaped openings facing the inner surface or the outer surface of the stent valve, or is provided with groove-shaped openings facing the inner surface of the stent valve.

上述人工心脏支架瓣膜,其中,所述的密封环可以由生物材料构成,也可以由合成材料构成。In the aforementioned artificial heart stent valve, the sealing ring may be made of biological material or synthetic material.

本发明的人工心脏支架瓣膜由于采用了上述的技术方案,使之与现有技术相比,具有以下的优点和积极效果:Compared with the prior art, the artificial heart stent valve of the present invention has the following advantages and positive effects due to the adoption of the above-mentioned technical scheme:

1、人工支架瓣膜形状、结构和功能更优化。1. The shape, structure and function of the artificial stent valve are more optimized.

2、可变形支架既可与生物瓣膜配合也可与合成瓣膜配合。2. The deformable stent can cooperate with biological valves or synthetic valves.

3、增加了合成瓣膜的强度和寿命,不需抗凝,可望代替生物瓣膜。3. Increase the strength and lifespan of the synthetic valve, without anticoagulation, and it is expected to replace the biological valve.

4、防止瓣膜开关时与金属支架接触磨擦,防止瓣膜周边血漏。4. Prevent the valve from contacting and rubbing against the metal stent when the valve is switched on and off, and prevent blood leakage around the valve.

5、人工支架瓣膜可径向压缩,在介入装置帮助下准确输送到位,然后扩张。扩张前和扩张时人工支架瓣膜不与输送装置发生事故性分离。如发现扩张过程中人工支架瓣膜位置不理想,可以纠正。5. The prosthetic stent valve can be radially compressed, accurately transported in place with the help of the interventional device, and then expanded. The prosthetic stent-valve does not accidentally separate from the delivery device before and during expansion. If it is found that the position of the artificial stent valve is not ideal during the expansion process, it can be corrected.

6、压缩状态下的人工支架瓣膜与鞘管之间摩擦力低,有利于精确释放人工支架瓣膜。6. The friction force between the artificial stent valve and the sheath tube in the compressed state is low, which is conducive to the precise release of the artificial stent valve.

7、扩张释放后的人工支架瓣膜在径向和轴向符合血管壁形状。7. After expansion and release, the artificial stent valve conforms to the shape of the blood vessel wall in the radial direction and the axial direction.

8、人工支架瓣膜植入后可发挥正常瓣膜的作用。8. The artificial stent valve can play the role of a normal valve after implantation.

9、人工支架瓣膜植入后,可防止在血液返流瓣膜关闭时,反方向血液造成人工瓣膜滑动。9. After the artificial stent valve is implanted, it can prevent the artificial valve from slipping caused by blood in the opposite direction when the blood regurgitation valve is closed.

10、扩张后的支架瓣膜不会产生瓣周漏。10. The expanded stent valve will not produce paravalvular leakage.

附图说明 Description of drawings

通过以下对本发明人工心脏支架瓣膜的多个实施例结合其附图的描述,可以进一步理解本发明的目的、具体结构特征和优点。其中,附图为:Through the following description of multiple embodiments of the artificial heart stent valve of the present invention in conjunction with the accompanying drawings, the purpose, specific structural features and advantages of the present invention can be further understood. Among them, the attached figure is:

图1为本发明人工心脏支架瓣膜中,网状支架整体呈圆管形的支架瓣膜的三维透视图;Fig. 1 is in the artificial heart stent valve of the present invention, the three-dimensional perspective view of the stent valve that the mesh stent is in the shape of a circular tube as a whole;

图1a为图1所示支架瓣膜的单层编织结构的平面展开图;Fig. 1 a is the plane development view of the single-layer braided structure of the stent valve shown in Fig. 1;

图2为本发明人工心脏支架瓣膜中,网状支架的中段呈鼓形的支架瓣膜的三维透视图;Fig. 2 is in the artificial heart stent valve of the present invention, the three-dimensional perspective view of the stent valve that the middle section of mesh support is drum-shaped;

图3为本发明人工心脏支架瓣膜中,网状支架的中段有径向突出结构的支架瓣膜的三维透视图;Fig. 3 is in the artificial heart stent valve of the present invention, the middle section of mesh support has the three-dimensional perspective view of the stent valve of radially protruding structure;

图3a为图3所示支架瓣膜的正视图。Fig. 3a is a front view of the stent-valve shown in Fig. 3 .

图3b为图3a的俯视图;Figure 3b is a top view of Figure 3a;

图3c为图3a的仰视图;Figure 3c is a bottom view of Figure 3a;

图3d为图3a的侧视图;Figure 3d is a side view of Figure 3a;

图3e和图3f为图3b沿侧轴bx横切示意图;Fig. 3e and Fig. 3f are cross-sectional schematic diagrams of Fig. 3b along the lateral axis bx;

图4为本发明人工心脏支架瓣膜中,网状支架的中段为圆管形内外双层结构的支架瓣膜的三维透视图;Fig. 4 is in the artificial heart stent valve of the present invention, and the middle section of mesh support is the three-dimensional perspective view of the stent valve of circular tubular inner and outer double-layer structure;

图4a为图4所示支架瓣膜的双层编织结构平面展开图;Figure 4a is a planar expansion view of the double-layer braided structure of the stent valve shown in Figure 4;

图5为本发明人工心脏支架瓣膜中,网状支架的中段有游离舌的支架瓣膜的三维透视图;Fig. 5 is in the artificial heart stent valve of the present invention, the three-dimensional perspective view of the stent valve with free tongue in the middle section of mesh support;

图5a为图5所示支架瓣膜的双层编织结构平面展开图;Fig. 5a is a plane development view of the double-layer braided structure of the stent valve shown in Fig. 5;

图5b为图5所示支架瓣膜的俯视图;Figure 5b is a top view of the stent valve shown in Figure 5;

图6为本发明人工心脏支架瓣膜中,网状支架的中段同时具有径向突出结构和游离舌的支架瓣膜的三维透视图。Fig. 6 is a three-dimensional perspective view of the stent valve of the artificial heart stent valve of the present invention, in which the middle section of the mesh stent has a radially protruding structure and a free tongue.

具体实施方式 Detailed ways

参见图1,配合参见图2、图3、图4、图5、图6,以及图10a、图10b、图10c、图10d、图10e、图10f,本发明的人工心脏支架瓣膜1包括:可径向变形的自扩张型网状支架10、不透x线标志311、312、可以开关并让血液单向通过的瓣膜叶33、密封膜351、354、密封环37、合成膜内加强纤维39和柔性联结环41。Referring to Fig. 1, refer to Fig. 2, Fig. 3, Fig. 4, Fig. 5, Fig. 6, and Fig. 10a, Fig. 10b, Fig. 10c, Fig. 10d, Fig. 10e, Fig. 10f, the artificial heart stent valve 1 of the present invention comprises: Radially deformable self-expanding mesh stent 10, X-ray-opaque markers 311, 312, valve leaflets 33 that can be switched on and off and allow blood to pass through in one direction, sealing membranes 351, 354, sealing rings 37, reinforcing fibers in the synthetic membrane 39 and flexible coupling ring 41.

瓣膜叶33,密封膜351、354,密封环37可以由生物材料制成,也可以由合成高分子材料制成。如由生物材料制成,瓣膜叶33、密封膜351、354和密封环37缝合于支架10上;如由合成高分子材料制成,自扩张型支架瓣膜1可以构成无缝合一体化的整体,这样可加强支架瓣膜1的强度,并使瓣膜叶33和密封膜351、354之间圆滑没有尖锐死边。The valve leaflets 33, the sealing membranes 351, 354, and the sealing ring 37 can be made of biological materials or synthetic polymer materials. If it is made of biological materials, the valve leaflets 33, sealing membranes 351, 354 and sealing ring 37 are sutured on the stent 10; if it is made of synthetic polymer materials, the self-expanding stent valve 1 can form a seamless integrated whole, In this way, the strength of the stent valve 1 can be enhanced, and the gap between the valve leaflet 33 and the sealing membranes 351 and 354 can be smooth without sharp dead edges.

可径向变形的自扩张型网状支架10为中央空心的管形网状结构,由弹性材料制成,在没有外力制约的情况下,支架扩张,为扩张状态。在外力作用下支架被径向压缩,为压缩状态。无论在自然状态或扩张状态下,自扩张型网状支架10均可按外轮廓分三个部分:即下游段13、中段15和上游段18。The radially deformable self-expanding mesh stent 10 is a central hollow tubular mesh structure made of elastic material, and the stent expands to an expanded state without external force constraints. Under the action of external force, the stent is radially compressed and is in a compressed state. No matter in the natural state or the expanded state, the self-expanding mesh stent 10 can be divided into three parts according to the outer contour: the downstream section 13 , the middle section 15 and the upstream section 18 .

下游段13就主动脉瓣膜来说,在逆血流入路情况下,对术者来说是支架的近端。本发明采用逆血流入路。在顺血流入路情况下,对术者来说是支架的远端。下游段13和升主动脉相配合。下游段13为以xx为长轴的绕轴转轮廓结构。自然状态或扩张状态下可为园管形和喇叭形两种形状。当下游段13为喇叭形时,其小口端靠下游段13与中段15交界带133,大口端靠下游端口134。下游段13长度可以因需要而变,小于50mm升主动脉长度。下游段13的下游端口134的末端可变形单元101可以在一个水平,也可以不在一个水平。下游段13的下游端口134的末端可变形单元101可以有开放式线拐102通向可变形单元101,也可以有密封式线眼103与可变形单元101分开。The downstream segment 13 is the proximal end of the stent for the operator in the case of a reverse blood flow path with respect to the aortic valve. The present invention adopts the reverse blood flow path. In the case of blood flow, it is the distal end of the stent to the operator. The downstream segment 13 fits with the ascending aorta. The downstream section 13 is an orbiting profile structure with xx as the major axis. Under the natural state or expanded state, it can be two kinds of shapes, garden tube shape and trumpet shape. When the downstream section 13 is trumpet-shaped, the small mouth end is close to the junction zone 133 between the downstream section 13 and the middle section 15 , and the large mouth end is close to the downstream port 134 . The length of the downstream segment 13 can be varied as required, and is less than 50 mm of the length of the ascending aorta. The deformable unit 101 at the end of the downstream port 134 of the downstream section 13 may or may not be at one level. The deformable unit 101 at the end of the downstream port 134 of the downstream section 13 may have an open wire turn 102 leading to the deformable unit 101 , or may have a sealed wire eye 103 separated from the deformable unit 101 .

中段15位于自扩张型网状支架10的中部。中段15和主动脉跟部冠状动脉窦和主动脉瓣膜叶相配合。其长度可以因需要而变,在15-30mm之间。中段15在自然状态或扩张状态下可分为三大类:1、以xx为长轴的绕轴转轮廓结构:包括圆管形结构151和鼓形结构152;2、以xx为长轴的绕轴转轮廓和以ax、bx、cx为侧轴的径向突出轮廓的复合结构,中段15具有径向突出结构153;3、内外双层结构:以前述两种轮廓结构,包括圆管形结构151、鼓形结构152和具有径向突出结构153的复合结构作为内层支架体154。内层支架体154之外有外层结构,包括外层环状结构155和游离舌156。内层154与外层155、156在下游段13或下游段13与中段15交界带133相连。中段15的某一可变形单元101可以有密封式线眼103与可变形单元101分开。The middle section 15 is located in the middle of the self-expanding mesh stent 10 . The middle section 15 cooperates with the coronary sinus of the heel of the aorta and the leaflets of the aortic valve. Its length can be changed according to needs, between 15-30mm. The middle section 15 can be divided into three categories in the natural state or in the expanded state: 1. The pivoting contour structure with xx as the long axis: including the circular tubular structure 151 and the drum-shaped structure 152; 2. The long axis with xx The composite structure of the profile around the axis and the radially protruding profile with ax, bx, and cx as the lateral axes, the middle section 15 has a radially protruding structure 153; 3, the inner and outer double-layer structure: with the aforementioned two profile structures, including the circular tube shape The structure 151 , the drum-shaped structure 152 and the composite structure with the radially protruding structure 153 serve as the inner support body 154 . There is an outer structure outside the inner stent body 154 , including an outer annular structure 155 and a free tongue 156 . The inner layer 154 and the outer layers 155 and 156 are connected at the junction zone 133 of the downstream section 13 or the downstream section 13 and the middle section 15 . A certain deformable unit 101 of the middle section 15 may be separated from the deformable unit 101 by a sealed line eye 103 .

本发明人工心脏支架瓣膜1中的网状支架的中段可有下述六种结构形式:The middle section of the mesh support in the artificial heart stent valve 1 of the present invention can have following six structural forms:

参见图1,配合参见图1a,图1是中段的第一种结构形式,在这种结构中,中段15为以xx为长轴的园管形151绕轴转轮廓。园管形151的中部有支架开口158。Referring to Fig. 1, referring to Fig. 1a, Fig. 1 is the first structural form of the middle section, in this structure, the middle section 15 is a garden tubular shape 151 with xx as the major axis turning around the profile. There is support opening 158 in the middle part of garden tubular shape 151 .

参见图2,图2是中段的第二种结构形式,在这种结构中,中段15为以xx为长轴的鼓型152绕轴转轮廓。鼓型152的中部157外径最大,大于下游段13与中段15交界带133的外径,大于上游段18与中段15交界带183的外径。鼓型152的中部157有支架开口158。Referring to Fig. 2, Fig. 2 is a second structural form of the middle section. In this structure, the middle section 15 is a drum-shaped 152 with xx as the major axis to rotate around the profile. The outer diameter of the middle part 157 of the drum 152 is the largest, which is larger than the outer diameter of the junction zone 133 between the downstream section 13 and the middle section 15 and larger than the outer diameter of the junction zone 183 between the upstream section 18 and the middle section 15 . The central portion 157 of the drum 152 has a bracket opening 158 .

参见图3,配合参见图3a、图3b、图3c、图3d、图3e、图3f,图3是中段的第三种结构形式。在这种结构中,中段15为复合结构,以xx为长轴的园管形151,或轻微的鼓型152绕轴转轮廓,外表面上有以ax、bx、cx为侧轴的一个或一个以上的径向突出结构153,径向向外延伸。ax、bx、cx侧轴垂直于xx长轴。ax、bx、cx三个侧轴之间以120度转角分配。以120度转角分配的径向突出结构153,用于和冠状动脉窦或自然主动脉瓣膜叶相配合。径向突出结构153为支架整体的一部分。每个径向突出结构153中部157x外径大,中心有一个较大的支架开口158。每个径向突出结构153的所有的周边159i、159o与绕轴转轮廓支架体相连。周边159i、159o的外径较突出结构中部157x的外径小,周边159i、159o分为二个半月形的上游周边159i和下游周边159o,以联合点160为界。半月形的上游周边159i构成与瓣膜叶33相连的瓣叶联合线331。二个相邻的径向突出结构153在联合点160相连,联合点160重叠合二为一。联合点160的外径较突出结构中部157x的外径小,构成瓣叶联合点332结合点。径向突出结构153至少为一叶。主动脉瓣膜处为120度转角分配的1-3叶。图3所示为具有三个径向突出结构153的网状支架。Referring to Fig. 3, refer to Fig. 3a, Fig. 3b, Fig. 3c, Fig. 3d, Fig. 3e, Fig. 3f for coordination. Fig. 3 is the third structure form of the middle section. In this structure, the middle section 15 is a composite structure, with xx as the long axis of the garden tube 151, or a slight drum-shaped 152 around the axis, and the outer surface has ax, bx, cx as one or More than one radial protruding structure 153 extends radially outward. The ax, bx, cx lateral axes are perpendicular to the xx long axis. The three side axes of ax, bx, and cx are distributed at 120-degree rotation angles. The radial projections 153 distributed at 120° rotation angle are used to cooperate with the coronary sinus or native aortic valve leaflets. The radially protruding structure 153 is an integral part of the stent. The middle portion 157x of each radially protruding structure 153 has a large outer diameter, and a large bracket opening 158 is formed in the center. All peripheries 159i, 159o of each radially protruding structure 153 are connected to the pivoting profile support body. The outer diameter of the periphery 159i, 159o is smaller than that of the middle part 157x of the protruding structure. The periphery 159i, 159o is divided into two half-moon-shaped upstream periphery 159i and downstream periphery 159o, bounded by the joint point 160. The upstream perimeter 159i of the half-moon forms the leaflet commissure line 331 connecting the valve leaflets 33 . Two adjacent radially protruding structures 153 are connected at a joint point 160, and the joint point 160 overlaps and merges into one. The outer diameter of the joint point 160 is smaller than that of the middle part 157x of the protruding structure, forming the joint point of the leaflet joint point 332 . The radial protruding structure 153 is at least one leaf. 1-3 leaflets allocated for 120° turn at the aortic valve. FIG. 3 shows a mesh stent with three radially protruding structures 153 .

参见图4,配合参见图4a,图4是中段的第四种结构形式。在这种结构中,中段15为圆管形内外双层结构,包括内层支架体154和外层环状结构155。内层支架体154和外层环状结构155在下游段13或下游段13与中段15交界带133相连,称固定缘161。外层环状结构155止于上游段18与中段15交界带183,呈游离状态或活动状态,称游离缘162。自然状态或扩张状态下内层支架体154和外层环状结构155内外两层支架平行。内层支架体154径向压缩状态下,以固定缘161为轴心,外层环状结构155可以径向压缩靠近内层支架体154,或去除向心制约力后扩张远离内层支架体154呈喇叭形向上游端口184开口。Referring to Fig. 4, see Fig. 4a for cooperation, Fig. 4 is the fourth structural form of the middle section. In this structure, the middle section 15 is a circular tube-shaped inner and outer double-layer structure, including an inner stent body 154 and an outer ring structure 155 . The inner stent body 154 and the outer annular structure 155 are connected at the downstream section 13 or the downstream section 13 with the junction zone 133 of the middle section 15 , which is called the fixed edge 161 . The outer annular structure 155 ends at the boundary zone 183 between the upstream section 18 and the middle section 15 , and is in a free or active state, called the free edge 162 . In a natural state or in an expanded state, the inner stent body 154 and the outer ring structure 155 are parallel to each other. When the inner stent body 154 is radially compressed, with the fixed edge 161 as the axis, the outer annular structure 155 can be radially compressed to approach the inner stent body 154, or expand away from the inner stent body 154 after removing the centripetal constraint force Opens to the upstream port 184 in a flared shape.

参见图5,配合参见图5a、图5b,图5是中段的第五种结构形式。在这种结构中,中段15为内外两层复合结构。以xx为长轴的园管形151,或轻微的鼓型152绕轴转轮廓的内层支架体154,外表面上有以dx、ex、fx为侧轴的一个或一个以上由单根网线围合而成的游离舌156,自下游段13或下游段13与中段15交界带133开始向外向上游端184延伸至上游段18与中段15交界带183止。dx、ex、fx侧轴垂直于xx长轴。dx、ex、fx三个侧轴之间以120度转角分配。三个120度转角分配的游离舌156,用于和冠状动脉窦或自然主动脉瓣膜叶相配合。游离舌156为支架整体的一部分。游离舌156一部分周边如下游周边与内层支架体154相连,称固定缘163,另一部分为舌形结构呈游离状态或活动状态,称游离缘164。二个相邻的游离舌156的固定缘163在联合点165相遇。联合点165与瓣叶联合点332结合点在同一旋转平面上。内层支架体154径向压缩状态下,以固定缘163为轴心,游离舌156可以径向压缩靠近内层支架体154,或去除向心制约力后扩张远离内层支架体154呈喇叭形向上游端口184开口。Referring to Fig. 5, refer to Fig. 5a and Fig. 5b for cooperation. Fig. 5 is the fifth structural form of the middle section. In this structure, the middle section 15 is a composite structure of inner and outer layers. The garden tubular shape 151 with xx as the major axis, or the inner layer support body 154 of the slight drum shape 152 around the axis, the outer surface has one or more single network cables with dx, ex, fx as the side axes The enclosed free tongue 156 starts from the downstream section 13 or the boundary zone 133 between the downstream section 13 and the middle section 15 and extends outward toward the upstream end 184 to the boundary zone 183 between the upstream section 18 and the middle section 15 . The dx, ex, fx lateral axes are perpendicular to the xx long axis. The three side axes of dx, ex, and fx are allocated at a 120-degree rotation angle. Three free tongues 156 assigned with 120-degree turning angles are used to cooperate with the coronary sinus or natural aortic valve leaflets. The free tongue 156 is an integral part of the bracket. A part of the periphery of the free tongue 156, such as the downstream periphery, is connected to the inner support body 154, which is called the fixed edge 163; The fixed edges 163 of two adjacent free tongues 156 meet at a joint point 165 . The joint point 165 and the leaflet joint point 332 are on the same rotation plane. When the inner stent body 154 is radially compressed, with the fixed edge 163 as the axis, the free tongue 156 can be radially compressed and close to the inner stent body 154, or expand away from the inner stent body 154 after removing the centripetal constraint force to form a trumpet shape Opens to upstream port 184 .

参见图6,图6是中段的第六种结构形式。在这种结构中,中段15为图3的径向突出结构153同时加有图5的游离舌156。径向突出结构153和游离舌156在同一角度位置上同时存在。游离舌156的游离缘164与径向突出结构153的周边159i、159o,至少半月形的上游周边159i在两个平行的曲面上重叠。Referring to Fig. 6, Fig. 6 is the sixth structural form of the middle section. In this structure, the middle section 15 is the radial protruding structure 153 of FIG. 3 and the free tongue 156 of FIG. 5 is added. The radial protruding structure 153 and the free tongue 156 exist simultaneously at the same angular position. The free edge 164 of the free tongue 156 overlaps the peripheries 159i, 159o of the radially protruding structure 153, at least the upstream peripheries 159i of the half-moon shape, on two parallel curved surfaces.

继续参见图1至图6,上游段18为与下游段13相反的另一端。上游段18和主动脉瓣膜环相配合。就主动脉瓣膜来说,在逆血流入路操作时,对术者来说为支架的远端。本发明采用逆血流入路。在顺血流入路操作时,对术者来说为支架的近端。上游段18为以xx为长轴的绕轴转轮廓结构。自然状态或扩张状态下可为园管形181(参见图1、图5)和喇叭形182(参见图2、图3、图4、图6)两种结构形状。园管形181是中段15呈园管形向上游端口184的延伸。喇叭形182是中段15呈喇叭形向上游端口184的开口延伸。喇叭形182小口径靠中段15,大口径为上游端口184。喇叭形182的上游端口184的直径远大于上游段18与中段15交界带183的直径。上游段18长度可以因需要而变,一般小于20mm,以不妨碍二尖瓣。上游段18不管是园管形181还是喇叭形182那种方案,上游段18上游端口184的末端可变形单元101可以在一个水平,上游端口184为平口。上游段18上游端口184的末端可变形单元101也可以不在一个水平。如:与三个半球形径向突出结构153同时存在,喇叭形182上游段18的上游端口184不在一个水平。与径向突出结构联合点160或瓣叶联合点332相对处喇叭形182上游段18较短,与径向突出结构153中部157x相对处喇叭形182上游段18较长,结果喇叭形182上游段18的上游端口184是与三个径向突出结构153相对应的三叶波浪形口185。上游段18上游端口184的末端可变形单元101可以有开放式线拐102通向可变形单元101,也可以有密封式线眼103与可变形单元101分开。Continuing to refer to FIGS. 1 to 6 , the upstream section 18 is the other end opposite to the downstream section 13 . The upstream segment 18 fits the aortic valve annulus. As far as the aortic valve is concerned, it is the distal end of the stent for the operator during the reverse blood flow operation. The present invention adopts the reverse blood flow path. When operating along the blood flow path, it is the proximal end of the stent for the operator. The upstream section 18 is an orbiting profile with xx as the major axis. Under the natural state or the expanded state, it can be in two structural shapes: a garden tubular shape 181 (see FIGS. 1 and 5 ) and a trumpet shape 182 (see FIGS. 2 , 3 , 4 , and 6 ). The garden pipe shape 181 is the extension of the middle section 15 to the upstream port 184 in the garden pipe shape. The trumpet shape 182 is that the middle section 15 extends toward the opening of the upstream port 184 in a trumpet shape. The trumpet-shaped 182 has a small diameter close to the middle section 15, and a large diameter is the upstream port 184. The diameter of the upstream port 184 of the trumpet shape 182 is much larger than the diameter of the junction zone 183 between the upstream section 18 and the middle section 15 . The length of the upstream segment 18 can be varied as required, and is generally less than 20 mm so as not to interfere with the mitral valve. Regardless of whether the upstream section 18 is in the form of a garden tube 181 or a trumpet 182, the deformable unit 101 at the end of the upstream port 184 of the upstream section 18 can be at a level, and the upstream port 184 is a flat opening. The deformable unit 101 at the end of the upstream port 184 of the upstream section 18 may not be at the same level. For example: with three hemispherical radially protruding structures 153 existing simultaneously, the upstream port 184 of the upstream section 18 of the trumpet-shaped 182 is not at the same level. The upstream section 18 of the trumpet 182 is relatively short at the joint point 160 of the radially protruding structure or the joint point 332 of the leaflets, and the upstream section 18 of the trumpet 182 is relatively long at the position opposite to the middle part 157x of the radially protruding structure 153, resulting in the upstream section of the trumpet 182 The upstream port 184 of 18 is a three-lobed wave-shaped mouth 185 corresponding to the three radially protruding structures 153 . The deformable unit 101 at the end of the upstream port 184 of the upstream segment 18 may have an open wire turn 102 leading to the deformable unit 101 , or may have a sealed wire eye 103 separated from the deformable unit 101 .

本发明采用可径向变形的自扩张型网状支架10。上述外轮廓是自扩张型网状支架10的自然状态或扩张状态。自扩张型网状支架10由弹性材料制成。已知的生物相容弹性材料包括镍钛形状记忆合金Nitinol、钴铬合金Phynox、L605,等。上述外轮廓网状支架很难是由塑性材料构成的球囊扩张型支架。因为这些外轮廓需要有特定外形的球囊扩张来达到。上述外轮廓的自扩张型网状支架10可以由弹性线材编织而成,也可以由弹性管材切割而成。The present invention adopts a radially deformable self-expanding mesh stent 10 . The above-mentioned outer contour is the natural state or expanded state of the self-expanding mesh stent 10 . The self-expanding mesh stent 10 is made of elastic material. Known biocompatible elastic materials include nickel-titanium shape memory alloy Nitinol, cobalt-chromium alloy Phynox, L605, and others. It is difficult for the above-mentioned outer contour mesh stent to be a balloon-expandable stent made of plastic material. Because these outer contours need to be expanded with a specific shape of the balloon to achieve. The self-expanding mesh stent 10 with the above outer contour can be woven from elastic wires, or can be cut from elastic tubes.

自扩张型编织网状支架10可以通过下述方法实施:The self-expanding braided mesh stent 10 can be implemented by the following methods:

自扩张型编织网状支架10的基本编织方法如下:The basic weaving method of the self-expanding braided mesh stent 10 is as follows:

参见图1a、图4a、图5a,配合参见图1至图6及图10a、图10b、图10c、图10d、图10e、图10f中的各图,自扩张型编织网状支架10由单个弹性编织线104编织而成。单个线104两末点105、106中的某一点比如起点105开始,沿前述特定的外轮廓151或152或153或154或155或156,181或182螺旋前进,到支架末端134、184后再折向对称的相反方向沿特定的外轮廓151或152或153或154或155或156,181或182螺旋前进。以此重复直到所有的可变形单元101都已建立,以两末点105、106中的某一点比如终点106到达或超过起点105结束。同一单个线104在折后的二段线104’相交时构成上下交错点107。一交错点107与最邻近的四个交错点107’的上下位置关系正好相反。一个可变形单元101是一个四边形或菱形结构,由同一单个线104在折后的四段线四个边104’和四个交错点107、107’构成。四个边的可变形单元101或由四个边可变形单元101编织的支架径向压缩变形,拌有轴向延长变形。单个编织线104到支架末端,如到上游端口184和下游端口134后,或到一可变形单元101末端后,再折向对称的相反方向构成小于360度的开放式线拐102。开放式线拐102的编织线104如果再转360度角可以构成密封式线眼103。密封式线眼103可以在支架两端,如上游端口184和下游端口134,也可以在这两者之间。每一段线上可以有一个或多个密封式线眼103。密封式线眼103可以与支架在同一外轮廓曲面上或切面上,也可以在与支架相垂直的平面上(径面上)向内或向外,也可以在这二者之间。支架末端,如上游端口184和下游端口134的开放式线拐102,密封式线眼103可以在同一水平,也可以在不同水平。对于三瓣膜叶支架瓣膜来说,沿周长的可变形单元数为三的倍数有利于三瓣膜叶对称。由单个编织线104编织的支架10的沿周长可变形单元数除以沿长轴可变形单元数应该是一个分数而不是一个整数。单个编织线104中的终点106到达起点105编织完一个支架后可以在同一位置上重复,包括:1、在所有位置上全部重复,这样就构成了二段线或二段线以上的径向强度更高的支架;2、在局部,如上游段、中段或下游段重复,二段线或二段线以上重复后的局部径向弹力增强。二段线至多段线可接近或重叠构成大小不一的可变形单元101,包括较大的开口158。由单个线编织而成的支架也可由多线编织而成。两个或多个相同或不同的单线可以同时编织在一起。每个单线构成一个支架。但两个或多个支架重叠在一起构成一个组合支架。不同的单线,粗细可以不同。不同的单线,材料可以不同。如其中一线可为不透X线材料的单线,如金、钨、铂、钽等。Referring to Fig. 1a, Fig. 4a, Fig. 5a, refer to Fig. 1 to Fig. 6 and Fig. 10a, Fig. 10b, Fig. 10c, Fig. 10d, Fig. 10e, Fig. The elastic braided wire 104 is braided. A certain point in the two end points 105, 106 of the single line 104, such as the starting point 105, starts along the aforementioned specific outer contour 151 or 152 or 153 or 154 or 155 or 156, 181 or 182 and advances spirally until the end of the stent 134, 184 Folding in the opposite direction of symmetry along a specific outer contour 151 or 152 or 153 or 154 or 155 or 156, 181 or 182 helical progress. This is repeated until all the deformable units 101 are established, and ends when one of the two end points 105 , 106 such as the end point 106 reaches or exceeds the start point 105 . The same single line 104 forms an up and down intersection point 107 when the folded two-segment lines 104' intersect. The up-down relationship between one intersecting point 107 and the four nearest intersecting points 107' is just opposite. A deformable unit 101 is a quadrilateral or rhombus structure, which is composed of four sides 104' of the same single line 104 folded and four intersecting points 107, 107'. The four-sided deformable units 101 or the stent braided by the four-sided deformable units 101 are radially compressed and deformed, mixed with axial elongated deformation. The single braided wire 104 goes to the end of the stent, such as after the upstream port 184 and the downstream port 134, or to the end of a deformable unit 101, and then folds to the symmetrical opposite direction to form an open wire bend 102 less than 360 degrees. If the braided wire 104 of the open wire turn 102 is turned 360 degrees again, the sealed wire eye 103 can be formed. The sealed wire eye 103 can be at both ends of the bracket, such as the upstream port 184 and the downstream port 134, or it can be between the two. There may be one or more sealed eyelets 103 on each segment. The sealed wire eye 103 can be on the same outer contour curved surface or tangent plane with the bracket, or can be inward or outward on a plane (diameter plane) perpendicular to the bracket, or can be in between. The end of the bracket, such as the open wire lug 102 of the upstream port 184 and the downstream port 134, the sealed wire eye 103 can be at the same level or at different levels. For a three-valve leaflet stent valve, the number of deformable units along the perimeter is a multiple of three, which is beneficial to the symmetry of the three valve leaflets. The number of deformable units along the perimeter of the stent 10 braided by a single braided wire 104 divided by the number of deformable units along the long axis should be a fraction rather than an integer. The end point 106 in the single braided line 104 arrives at the starting point 105 and can be repeated at the same position after braiding a stent, including: 1. All repeats at all positions, so that the radial strength of the two-segment line or above the two-segment line is formed Higher stent; 2. In the local area, such as the upstream section, the middle section or the downstream section, the local radial elastic force is enhanced after repeating the two-segment line or above the two-segment line. Two-segment lines to multi-segment lines can approach or overlap to form deformable units 101 of different sizes, including larger openings 158 . Stents woven from a single wire can also be woven from multiple wires. Two or more same or different single threads can be braided together at the same time. Each single line constitutes a bracket. However, two or more stents overlap to form a combined stent. Different single lines can have different thicknesses. Different single wires, materials can be different. For example, one line can be a single line of radiopaque material, such as gold, tungsten, platinum, tantalum, etc.

以下介绍本发明人工心脏支架瓣膜1中的网状支架的上述几种结构的具体编织方法:The specific weaving method of the above-mentioned several structures of the mesh support in the artificial heart stent valve 1 of the present invention is introduced below:

中段采用第一种结构的编织方法:The middle section adopts the weaving method of the first structure:

以xx为长轴的园管形151、181绕轴转轮廓支架的编织方法同基本编织方法。Take xx as the garden tubular shape 151,181 of major axis and turn the braiding method of contour support with basic braiding method around the axis.

中段采用第二种结构的编织方法:The middle section adopts the weaving method of the second structure:

下游段13为以xx为长轴的园管形,中段15为鼓型或园球形152,上游段18为喇叭形182的绕轴转轮廓支架的编织方法同基本编织方法。支架从上游端口184到下游端口134之间的每一段编织丝104’的长度一样。Downstream section 13 is the garden tubular shape with xx as major axis, and middle section 15 is drum type or garden spherical 152, and upstream section 18 is the same basic braiding method that the braiding method of turning the profile support around the axis of trumpet-shaped 182. The length of each braided wire 104' from the upstream port 184 to the downstream port 134 of the stent is the same.

中段采用第三种结构的编织方法:The middle section adopts the braiding method of the third structure:

在编织方法二基础上,以xx为长轴的园管形151,或轻微的鼓型或园球形152绕轴转轮廓,中段15外表面上有以ax、bx、cx为侧轴的一个或一个以上的径向突出结构153径向向外延伸的复合结构支架。这种轮廓支架的编织方法类似基本编织方法。中段15为径向突出结构153的支架可由单个编织线104编织而成。由单个编织线104编织而成的支架从下游端口134经过三个半球形径向突出结构153不同部位,如中部157x或联合点160,到上游段18与中段15交界带183止每一段编织线的长度不一样,相邻可变形单元不等长。但编织支架交错点107、107’上相邻段编织线之间的滑动,保证了支架和径向突出结构153可以径向压缩,径向扩张。与三个半球形径向突出结构153同时存在,喇叭形182上游段18与径向突出结构联合点160或瓣叶联合点332相对处较短,喇叭形182上游段18与径向突出结构153中部157x相对处较长,结果喇叭形182上游段18是与三个径向突出结构相对的三叶波浪形口185。喇叭形182上游段18较长处的编织线经过相邻径向突出结构联合点160或瓣叶联合点332较小外径,喇叭形182上游段18较短处的编织线经过径向突出结构中部157x较大外径。这样支架从上游端口184经过三个径向突出结构153到下游端口134之间的每一段编织丝的长度可以一样。各段线在扩张状态及压缩下状态均等长。扩张状态下支架上游端口184呈三个波浪形边185与三个径向突出结构153相对应。径向压缩、轴向延长时,交错点上相邻段线滑动,三个径向突出结构153和三波浪形边185消失,上游端口184各可变形单元平行。单线104不仅可以编织成一个单层网状壳支架10,还可编织成一个多层的立体结构支架。On the basis of braiding method 2, take xx as the garden tubular shape 151 of major axis, or slight drum shape or garden spherical shape 152 turns around the profile, and middle section 15 outer surface has with ax, bx, cx one or More than one radially protruding structure 153 extends radially outwardly to support the composite structure. The weaving method for this contour support is similar to the basic weaving method. The stent whose middle section 15 is a radially protruding structure 153 can be braided by a single braided wire 104 . The stent braided by a single braided wire 104 passes through different parts of the three hemispherical radially protruding structures 153 from the downstream port 134, such as the middle part 157x or the joint point 160, to the junction zone 183 between the upstream section 18 and the middle section 15, and stops at each section of the braided wire The lengths are not the same, and the adjacent deformable units are not equal in length. However, the sliding between adjacent sections of the braided wires at the intersecting points 107, 107' of the braided stent ensures that the stent and the radially protruding structure 153 can be radially compressed and radially expanded. There are three hemispherical radial protruding structures 153 at the same time, and the upstream section 18 of the trumpet-shaped 182 is relatively short at the joint point 160 of the radial protruding structure or the joint point 332 of the leaflets, and the upstream section 18 of the trumpet-shaped 182 is connected to the radial protruding structure 153 The central portion 157x is comparatively longer so that the upstream section 18 of the trumpet 182 is a three-lobed undulating mouth 185 opposite the three radially protruding structures. The braided wire at the longer part of the upstream section 18 of the trumpet-shaped 182 passes through the joint point 160 of the adjacent radially protruding structure or the smaller outer diameter of the leaflet joint point 332, and the braided wire at the shorter part of the upstream section 18 of the trumpet-shaped 182 passes through the middle part 157x of the radially protruding structure Larger outer diameter. In this way, the length of each segment of the braided wire between the upstream port 184 passing through the three radially protruding structures 153 and the downstream port 134 can be the same. Each segment line is equal in length under expansion state and under compression state. In the expanded state, the upstream port 184 of the stent has three wavy sides 185 corresponding to the three radially protruding structures 153 . When radially compressed and axially extended, the adjacent segments at the intersection point slide, the three radially protruding structures 153 and the three wavy sides 185 disappear, and the deformable units of the upstream port 184 are parallel. The single wire 104 can not only be woven into a single-layer reticular shell support 10, but also can be woven into a multi-layer three-dimensional structure support.

中段采用第四种结构的编织方法:The middle section adopts the braiding method of the fourth structure:

单线104编织成一个单层网状壳支架10后,在支架下游段13,同一编织单线104的另一段104’双段线局部原位重复。到中段15单线104伸出并脱离已编织好的内层支架体154并单独编外层环状结构155。编了外层环状结构155的中段15单线104再回到支架体下游段13双段线局部原位重复,以此下游段支架体13和中段15外层环状结构155来回重复并转支架约360度转角,直至构成如图4a所示的外层环状结构155。这样中段有内外两层支架154、155。两层之间在中下游段之间相连为固定缘161。自下游段13和中段15结合带133开始外层环状结构155向外向上游端口184延伸至中段15和上游段18之间的结合带183水平止。这些外层环状结构155径向压缩下有利于输送。内层支架体154径向压缩下,以固定缘161为轴心,外层环状结构155可以单独于内层支架体154径向压缩靠近内层支架体154或去除向心制约力后经向释放扩张远离内层支架体154呈喇叭口形。独立于内层支架体154压缩或扩张状态,这些外层环状结构155单独扩张起定位,固定作用。内层支架体154和外层环状结构155扩张状态下这些外层环状结构155可以平贴于内层支架体154外表面上,也可以呈喇叭形向上游端口184延伸于支架体外表面上。支架下游段13双段线重复部分加中段外层环状结构155的周长细胞数CN’与轴长细胞数LN’的比例不为一个整数。这些外层环状结构155不仅可以由与内层支架体154同一单线104编织而成,也可以由与内层支架体154不同的编织线一齐编织而成。After the single wire 104 is braided into a single-layer reticular shell stent 10, another section 104' of the same braided single wire 104 is locally repeated in situ at the downstream section 13 of the bracket. To the middle section 15, the single wire 104 stretches out and breaks away from the braided inner layer stent body 154 and braids the outer layer ring structure 155 separately. The middle section 15 single line 104 of the outer ring structure 155 is compiled and then returned to the downstream section 13 of the bracket body to repeat in situ, so that the downstream section bracket body 13 and the middle section 15 outer ring structure 155 repeat back and forth and rotate the bracket Turn about 360 degrees until the outer ring structure 155 as shown in FIG. 4a is formed. There are inner and outer two-layer supports 154,155 in the middle section like this. The two layers are connected as a fixed edge 161 between the middle and downstream sections. The outer annular structure 155 extends outwardly from the junction zone 133 of the downstream section 13 and the middle section 15 to the upstream port 184 to the level of the junction strip 183 between the middle section 15 and the upstream section 18 . The radial compression of these outer annular structures 155 facilitates delivery. Under the radial compression of the inner stent body 154, with the fixed edge 161 as the axis, the outer annular structure 155 can be radially compressed independently of the inner stent body 154 and close to the inner stent body 154 or after the centripetal restriction force is removed. The release expands away from the inner stent body 154 in a bell mouth shape. Independent of the compressed or expanded state of the inner stent body 154, these outer ring structures 155 expand independently to perform positioning and fixation. In the expanded state of the inner stent body 154 and the outer annular structure 155, these outer annular structures 155 can be flatly attached to the outer surface of the inner stent body 154, or can be trumpet-shaped and extend toward the upstream port 184 on the outer surface of the stent body. . The ratio of the number of perimeter cells CN' to the number of axial cells LN' in the repeated part of the double-segment line in the downstream section 13 of the stent plus the outer ring structure 155 in the middle section is not an integer. These outer ring structures 155 can not only be braided by the same single wire 104 as the inner stent body 154 , but also can be braided by different braided wires from the inner stent body 154 .

中段采用第五种结构的编织方法:The middle section adopts the fifth structure weaving method:

单线104编织成一个单层网状壳支架10后,在支架下游段13,同一编织单线104的另一段104’双段线局部原位重复,并转支架约60度角,到中段15单线104’伸出并脱离已编织好的支架体154打一半圆弧线166或打一整圆弧线166’再回到支架下游段13双段线局部原位重复。这样单线104出点167与进点167’,或进点167与出点167’之间支架转120度。以此下游段支架体13和中段15外层游离舌156来回重复三次直至构成如图5a所示的外层游离舌156。这样中段有内层支架体154和外层游离舌156两层支架结构。两层之间在中下游段之间相连为固定缘163。自下游段13和中段15之间结合带133开始外层游离舌156向外向上游端184延伸至中段15和上游段18之间结合带183水平止。两相邻外层游离舌156各自的固定缘163有一共同的联合点165。这些外层游离舌156径向压缩下有利于输送。支架体径向压缩下,以固定缘163为轴心,外层游离舌156可以单独于内层支架体154径向压缩靠近支架体,或去除向心制约力后径向释放扩张远离支架体呈喇叭口形。支架体154扩张前,单独扩张的外层游离舌156,可以先顶到主动脉瓣的天然瓣膜叶袋内起自动定位作用。不管支架体处于压缩状态还是扩张状态,这些外层游离舌156可以独立径向压缩,独立径向释放扩张起固定作用。这些外层游离舌156进入自然瓣膜叶袋,压在天然瓣膜叶袋底和自然瓣叶联合点。在心脏舒张期支架瓣膜的瓣膜叶关闭时,血液反流,外层游离舌156可以起固定作用,防止支架瓣膜被血流冲进左心室内。内层支架体154和外层游离舌156扩张状态下这些外层游离舌156可以平贴于支架体外表面上,也可以呈喇叭形向上游端的开口延伸于支架体外表面上。下游段13同一编织单线104的双段线局部重复的周长可变形单元数CN与轴长可变形单元数LN的比例为一个整数,这样保证单线回到原点105、106。单线出点167和进点167’之间可以是一个半弧形166,也可以是一个360度以上套环形166’。套环166’可以全游离,也可以下游段重新编入支架体内。外层游离舌156为自扩张型单线支架整体的一部分。外层游离舌156有二到三个,之间120度角。外层游离舌156一般为半月弧形,弧形线两端连接在支架体上。外层游离舌156还可有其他变化方案。如:1、弧顶打360度弯构成一个小圆圈以增加变形弹力;2、弧顶打360度弯构成一个大圆圈,大圆圈的半径几乎同半弧线半径;3、打360度大圆圈的下游端重新编入下游支架体。外层游离舌156因为线少,故弹力低于支架体154。在血管腔内低弹力的外层游离舌156不妨碍支架体扩张。外层游离舌156和支架体截面大小和形态在扩张状态下一致。这些外层游离舌156不仅可以由与内层支架体154同一单线104编织而成,也可以由与内层支架体154不同的编织线一齐编织而成。After the single wire 104 is braided into a single-layer reticulated shell bracket 10, in the downstream section 13 of the bracket, another section 104' of the same braided single wire 104 is partially repeated in situ, and the bracket is rotated at an angle of about 60 degrees to reach the middle section 15 of the single wire 104 'Stretch out and break away from the already braided stent body 154 to make a half-arc line 166 or a full-arc line 166' and then return to the downstream section of the stent 13 and repeat the double-segment line locally. Single line 104 exit point 167 and entry point 167 ' like this, or support turns 120 degrees between entry point 167 and exit point 167 '. In this way, the downstream segment stent body 13 and the outer layer free tongue 156 of the middle segment 15 repeat back and forth three times until the outer layer free tongue 156 as shown in FIG. 5a is formed. Middle section has inner layer stent body 154 and outer layer free tongue 156 two-layer stent structure like this. The two layers are connected by a fixed edge 163 between the middle and downstream sections. The free tongue 156 of the outer layer starts from the bonding zone 133 between the downstream section 13 and the middle section 15 and extends outward to the upstream end 184 to the level of the bonding zone 183 between the middle section 15 and the upstream section 18 . The respective fixed edges 163 of two adjacent outer layer free tongues 156 have a common joint point 165 . The radial compression of these outer free tongues 156 facilitates delivery. Under the radial compression of the stent body, with the fixed edge 163 as the axis, the outer free tongue 156 can be radially compressed separately from the inner stent body 154 and approach the stent body, or released and expanded radially away from the stent body after the centripetal constraint force is removed. Bell mouth shape. Before the expansion of the stent body 154, the independently expanded outer free tongue 156 can first push into the natural valve leaflet bag of the aortic valve for automatic positioning. Regardless of whether the stent body is in a compressed state or an expanded state, these outer free tongues 156 can be independently radially compressed, and independently radially released and expanded to play a fixing role. These outer free tongues 156 enter the natural valve leaflet pockets and press against the bottom of the natural valve leaflet pockets and the natural valve leaflet juncture. When the valve leaflets of the stent valve are closed during diastole, the blood flows back, and the outer free tongue 156 can play a fixing role to prevent the stent valve from being rushed into the left ventricle by the blood flow. When the inner stent body 154 and the outer free tongue 156 are expanded, these outer free tongues 156 can be flatly attached to the outer surface of the stent, or can be trumpet-shaped and extend to the opening at the upstream end on the outer surface of the stent. The ratio of the number of perimeter deformable units CN to the number of axial length deformable units LN of the partially repeated double-segment line of the same braided single line 104 in the downstream section 13 is an integer, so as to ensure that the single line returns to the origin 105, 106. A semi-arc 166 can be formed between the single-line exit point 167 and the entry point 167 ', and it can also be a ring 166 ' above 360 degrees. The collar 166' can be completely dissociated, or can be re-embedded in the stent body in the downstream section. The outer free tongue 156 is an integral part of the self-expandable single wire stent. Outer layer free tongue 156 has two to three, 120 degree angles between. The outer free tongue 156 is generally half-moon arc-shaped, and the two ends of the arc line are connected to the support body. The outer free tongue 156 also has other variations. Such as: 1. Make a 360-degree bend at the top of the arc to form a small circle to increase the deformation elasticity; 2. Make a 360-degree bend at the top of the arc to form a large circle, and the radius of the large circle is almost the same as the half-arc radius; 3. Make a 360-degree large circle The downstream end of the stent is reprogrammed into the downstream support body. The free tongue 156 of the outer layer has less elastic force than the support body 154 because there are few lines. The outer free tongue 156 with low elasticity in the vessel lumen does not hinder the expansion of the stent body. The size and shape of the outer free tongue 156 and the cross-section of the stent body are consistent in the expanded state. These outer free tongues 156 can not only be woven by the same single wire 104 as the inner layer stent body 154 , but also can be woven together by different braided wires from the inner layer stent body 154 .

中段采用第六种结构的编织方法::The middle section adopts the weaving method of the sixth structure:

为编织方法三的径向突出结构153同时加有编织方法五的游离舌156。支架可以同时有大小、形状、位置、数量一致的径向突出结构153和外层游离舌156。径向压缩后,外层游离舌156先释放扩张,与自然瓣膜杯相对应后嵌入自然瓣膜杯,以此达到旋转定位和轴长定位。然后径向突出结构153和支架体扩张。外层游离舌156因为线少,故弹力低于支架体。在血管腔内低弹力的外层游离舌156不妨碍支架体扩张。径向突出结构153和外层游离舌156均起固定作用。二者153和156将自然瓣膜叶夹在中间起密封作用。The radial protruding structure 153 of the braiding method three is added with the free tongue 156 of the braiding method five. The stent can simultaneously have radially protruding structures 153 and outer free tongues 156 with the same size, shape, position, and number. After radial compression, the outer free tongue 156 is first released and expanded, corresponding to the natural valve cup and then embedded in the natural valve cup, so as to achieve rotational positioning and axial length positioning. The radially protruding structure 153 and stent body are then expanded. Outer layer free tongue 156 is because the line is few, so elastic force is lower than support body. The outer free tongue 156 with low elasticity in the vessel lumen does not hinder the expansion of the stent body. Both the radially protruding structure 153 and the outer free tongue 156 play a role in fixing. Both 153 and 156 sandwich the natural valve leaflets for sealing.

本发明中的开放式线拐102和密封式线眼103也可以由管形材料切割而成。径向突出结构153也可以由管形材料切割变形而成。外层环状结构155和外层游离舌156也可以由管形材料切割变形而成,然后焊接在一起。The open wire bend 102 and the sealed wire eye 103 in the present invention can also be cut from tubular material. The radial protruding structure 153 can also be formed by cutting and deforming a tubular material. The outer annular structure 155 and the outer free tongue 156 can also be formed by cutting and deforming tubular materials, and then welded together.

继续参见图1至图6,本发明人工心脏支架瓣膜1中设有不透X线标志,包括点状标志311和线状标志312。Continuing to refer to FIG. 1 to FIG. 6 , the artificial heart stent valve 1 of the present invention is provided with radiopaque markers, including point markers 311 and linear markers 312 .

点状不透X线标志311可以为管型,同轴套在一个或一个以上编织线104上。支架的下游端134至少有一个或一个以上的不透X线点状标志311。支架的上游端184或上游段与中段交界处183至少有一个或一个以上不透X线点状标志311,这些标志的位置靠近瓣膜叶的杯底。支架的中段15至少有一个或一个以上不透X线点状标志311,这些标志的位置可位于二个径向突出结构153相联的结合点160,相当二相邻于瓣膜叶的联合点332的位置。The dot-like radiopaque markers 311 can be tube-shaped, coaxially sheathed on one or more braided wires 104 . The downstream end 134 of the stent has at least one or more X-ray-opaque point markers 311 . The upstream end 184 of the stent or the junction 183 between the upstream section and the middle section has at least one or more X-ray-opaque dot-shaped marks 311 , and these marks are located close to the cup bottom of the valve leaflet. The middle section 15 of the stent has at least one or more X-ray-opaque point markers 311, and the position of these markers can be located at the joint point 160 where the two radially protruding structures 153 are connected, corresponding to two joint points 332 adjacent to the valve leaflets. s position.

参见图5,从支架的上游段18与中段15联合区线183起,到中段中部157止,一根不透X线的标志线312做成二至三个波形,并头尾相连。标志线312在支架编织网线104中上下穿梭。此标志线相邻于瓣膜叶与支架的结合线331。支架内三波形标志线可用于固定生物瓣膜叶于支架上。Referring to FIG. 5 , from the joint area line 183 of the upstream section 18 and the middle section 15 of the stent to the middle section 157 , an X-ray-opaque marking line 312 is made into two to three waveforms and connected end to end. The marking line 312 shuttles up and down in the stent braided mesh line 104 . This marking line is adjacent to the joint line 331 of the valve leaflet and the stent. The three wave marking lines in the stent can be used to fix the biological valve leaflets on the stent.

不透X线的材料可以是金、钨、铂、钽等生物相容的重金属。The radiopaque material can be biocompatible heavy metals such as gold, tungsten, platinum, and tantalum.

继续参见图1至图6,本发明人工心脏支架瓣膜1中的瓣膜叶33可以有二至三个,如为三个瓣膜叶则呈120度转角分配。每个瓣膜叶包括游离边333和关闭边334。游离边333和关闭边334之间为关闭区335。瓣膜叶杯呈弧形,分为降区和升区。杯底可略低于瓣膜叶与支架的联合线331。瓣膜叶和支架相结合处构成联合线331。二个相邻的瓣膜叶的联合线相通构成瓣叶联合点332。瓣叶联合点332在编织线104交错点107、107’上。瓣叶联合点332相当于瓣膜叶关闭边334的水平。瓣膜叶由柔软的材料制成,自然状态为关闭状态,相邻的瓣膜叶的游离边333和关闭边334之间的关闭区335相接触,瓣膜关闭,血液不能通过。心脏舒张期主动脉内血管舒张压使瓣膜叶关闭更紧。心脏收缩期血液冲过瓣膜叶33,使瓣膜叶33贴向支架或血管壁,支架瓣膜1打开。瓣膜叶33可以由生物材料构成,也可以由合成材料构成。合成材料可以是弹性体,如硅胶或聚氨酯。合成材料瓣膜叶内有一条至多条加强纤维39,起止于同一瓣膜叶33的两个不同的瓣叶联合点332或联合线331,连在支架上10。加强纤维39主要在瓣膜叶的主动脉面340侧,使瓣膜叶面为线状面,而瓣膜叶心室面341侧为光面。Continue referring to Fig. 1 to Fig. 6, the valve leaflet 33 in the artificial heart stent valve 1 of the present invention can have two to three, if be three valve leaflets, then be 120 degree distribution. Each valve leaflet includes a free edge 333 and a closing edge 334 . Between the free side 333 and the closing side 334 is a closing area 335 . The leaflet cups of the valve are curved and divided into a descending zone and an ascending zone. The bottom of the cup can be slightly lower than the joint line 331 between the valve leaflet and the stent. The junction line 331 is formed at the junction of the valve leaflet and the stent. The joint line of two adjacent valve leaflets communicates to form the leaflet joint point 332 . The leaflet commissure point 332 is at the crossing point 107, 107' of the braided wire 104. The leaflet commissure point 332 corresponds to the level of the closing edge 334 of the valve leaflet. The valve leaflets are made of soft materials, and the natural state is a closed state. The closing area 335 between the free edge 333 and the closing edge 334 of the adjacent valve leaflets is in contact, and the valve is closed so that blood cannot pass through. Vasodilation in the aorta during diastole causes the valve leaflets to close more tightly. During systole, the blood rushes through the valve leaflet 33, making the valve leaflet 33 stick to the stent or the vessel wall, and the stent valve 1 opens. The valve leaflets 33 may be composed of biological or synthetic materials. The synthetic material can be an elastomer such as silicone or polyurethane. There are one or more reinforcing fibers 39 in the valve leaflet of synthetic material, starting and ending at two different leaflet joint points 332 or joint lines 331 of the same valve leaflet 33, and connected to the bracket 10. The reinforcing fibers 39 are mainly on the aortic surface 340 side of the valve leaflet, so that the valve leaflet surface is a linear surface, while the ventricular surface 341 side of the valve leaflet is a smooth surface.

继续参见图1至图6,本发明人工心脏支架瓣膜1中设有密封膜,包括上游段密封膜351和中段密封膜354。Continuing to refer to FIG. 1 to FIG. 6 , the artificial heart stent valve 1 of the present invention is provided with a sealing film, including an upstream sealing film 351 and a middle sealing film 354 .

在支架上游段18圆管形181或喇叭形开口182包有密封膜351。此密封膜可以在支架以外向上游方向延伸构成没有支架支承的软膜352。此密封膜可以在支架以内向下游方向延伸到瓣叶联合线331。此密封膜在支架上游端口184,开放式线拐102或密封式线眼103处,至少有一个内外相通的密封膜眼353,供输放装置2的支架拉线70通过。此上游段密封膜351保证心脏收缩时血液不从支架瓣膜1同边漏过。软膜边缘352保证心脏收缩时与自然二尖瓣叶接触时不使其受损伤。A sealing film 351 is wrapped around the round tube 181 or trumpet-shaped opening 182 of the bracket upstream section 18 . The sealing membrane may extend upstream of the stent to form a pia 352 without stent support. This sealing membrane may extend in a downstream direction within the stent to the commissure line 331 . This sealing film has at least one internally and externally communicating sealing film eye 353 at the support upstream port 184, the open line turn 102 or the sealed line eye 103, for the support backguy 70 of the delivery device 2 to pass through. The upstream sealing film 351 ensures that blood does not leak from the same side of the stent valve 1 when the heart contracts. The pial border 352 ensures that the native mitral valve leaflets are not damaged during systole contact.

上游段密封膜351从瓣叶结合线331继续向下游方向延伸构成中段密封膜354。中段密封膜354为沿瓣叶结合线331几乎等宽的波状形膜带。在径向突出结构153中部157x没有膜。波状膜带在联合点160、332处较窄,保证血液流向冠脉。在心脏舒张期,中段密封膜354在主动脉血液返流冲击下顶向血管壁,保证了心脏舒张期血液不从支架瓣膜1同边漏过经主动脉返流到左心室。中段密封膜354边起到支架下游段没有密封膜,保证了血液在心脏舒张期向侧枝如冠脉灌流。保证以后冠脉介入。The upstream sealing membrane 351 continues to extend downstream from the leaflet joint line 331 to form a middle sealing membrane 354 . The mid-section sealing membrane 354 is a wavy membrane strip with almost equal width along the leaflet joint line 331 . In the middle portion 157x of the radially protruding structure 153 there is no membrane. The corrugated membranous band is narrower at the junctions 160, 332, allowing blood flow to the coronary arteries. During diastole, the middle sealing membrane 354 pushes against the vessel wall under the impact of aortic blood reflux, ensuring that blood does not leak from the same side of the stent valve 1 and flow back to the left ventricle through the aorta during diastole. The sealing membrane 354 in the middle section has no sealing membrane in the downstream section of the stent, which ensures blood perfusion to side branches such as coronary arteries during diastole. Guaranteed future coronary intervention.

支架下游段13不设密封膜,保证了血液在心脏舒张期向侧枝如冠脉搭桥入口灌流。The downstream section 13 of the stent is not provided with a sealing membrane, which ensures that the blood perfuses to the entrance of side branches such as coronary artery bypass grafts during diastole.

没有密封膜的可变形单元101的金属支架线上包括交错点107、107’上可包有弹性合成材料。The metal frame wires of the deformable unit 101 without a sealing membrane, including the crossing points 107, 107', can be wrapped with elastic synthetic material.

密封膜351、354可以是生物膜或合成膜。生物膜可以在支架内侧、外侧,或内外侧同时存在。The sealing membranes 351, 354 may be biological or synthetic membranes. Biofilms can exist on the inside, outside, or both inside and outside of the stent.

合成密封膜351、354可以是弹性体如硅胶,将支架包在中间。Synthetic sealing membranes 351, 354, which may be elastomers such as silicone, wrap the stent in between.

继续参见图1至图6,合成密封膜351、354内可含有加强纤维39,呈圆周环形放置,并与支架相连或联结。加强纤维39可处于合成密封膜边界,如软膜352边缘和中段密封膜354边缘。合成密封膜可由弹性高分子材料组成,如硅胶、胶乳、聚氨酯。凌形或其它形状的可变形单元被弹性体包围,径向压缩时,凌形可变形单元沿纵轴XX延长,沿垂直的横轴缩短。纵轴XX延长使弹性高分子材料弹性延长,外力除去后凌形可变形单元要恢复原来的长度,弹性高分子材料使支架产生额外的径向向外的膨胀力。压缩后支架变长,材料向两侧流动,每一截面上材料减少,有利于降低支架瓣膜压缩状态下的外径。Continuing to refer to FIG. 1 to FIG. 6, the composite sealing membranes 351, 354 may contain reinforcing fibers 39, placed in a circumferential ring, and connected or bonded to the stent. Reinforcing fibers 39 may be at the edges of the composite sealing membrane, such as the edge of the soft membrane 352 and the edge of the midsection sealing membrane 354 . Synthetic sealing membranes can be composed of elastic polymer materials such as silicone, latex, polyurethane. The deformable unit in the shape of a lobe or other shapes is surrounded by elastic body, and when compressed radially, the deformable unit in the shape of a loom is extended along the longitudinal axis XX and shortened along the vertical horizontal axis. The extension of the longitudinal axis XX makes the elastic polymer material stretch elastically. After the external force is removed, the Ling-shaped deformable unit will restore its original length, and the elastic polymer material causes the stent to generate an additional radially outward expansion force. After compression, the stent becomes longer, the material flows to both sides, and the material on each section is reduced, which is beneficial to reduce the outer diameter of the stent valve under compression.

参见图3,本发明人工心脏支架瓣膜1中还可以设有密封环37,密封环37为一柔软的管状结构,环绕支架一周,位于支架上游段18与中段15交界带183的支架外侧,可以呈绕XX轴的环形或沿联合线331的三波浪形。管状结构可以是密封式,也可以是半开放式。半开放式的密封环37上有点状开口373(参见图3f)朝向支架瓣膜1内面或外面,或有槽状开口373’(参见图3e)朝向支架瓣膜1内面。管状结构可以由生物材料或合成材料构成。它可以和密封膜35相连。支架扩张后顶着血管壁,管状密封环37可被压缩使其适应,填补支架与血管壁之间的缝隙。Referring to Fig. 3, sealing ring 37 can also be provided in the artificial heart stent valve 1 of the present invention, and sealing ring 37 is a soft tubular structure, surrounds support for a week, is positioned at the support outside of support upstream section 18 and middle section 15 junction zone 183, can It is in the shape of a ring around the XX axis or three waves along the joint line 331. The tubular structure can be sealed or semi-open. The semi-open sealing ring 37 has a dotted opening 373 (see FIG. 3f ) towards the inner or outer surface of the stent valve 1, or has a grooved opening 373′ (see FIG. 3e ) towards the inner surface of the stent valve 1 . The tubular structure can be constructed from biological or synthetic materials. It can be connected to the sealing membrane 35 . After the stent expands against the vessel wall, the tubular sealing ring 37 can be compressed to adapt to fill the gap between the stent and the vessel wall.

本发明人工心脏支架瓣膜1中采用的弹性合成材料膜内设有加强纤维39。与生物材料构成的瓣膜叶和密封膜不同,弹性合成材料构成的瓣膜叶33和密封膜351、354内可以有加强纤维39。合成材料瓣膜叶内有一条至多条加强纤维39,起止于同一瓣膜叶的两个不同的联合点332或联合线331,连在支架10上;加强纤维39可以处在瓣膜叶33的游离边333,主要在瓣膜叶的下游面340,使瓣膜叶下游面主动脉侧340为线条状皱面,而瓣膜叶上游面心室侧341为光面。加强纤维39的材料包括涤纶纤维、高分子聚乙烯纤维、尼龙和碳纤维等。加强纤维39可以选择性加强弹性合成材料膜的强度,还可加强合成膜与支架间的强度。加强纤维39还可以处在不透X线标志311、312上。The elastic synthetic material membrane adopted in the artificial heart stent valve 1 of the present invention is provided with reinforcing fibers 39 . Unlike valve leaflets and sealing membranes made of biological materials, valve leaflets 33 and sealing membranes 351 , 354 made of elastic synthetic material may have reinforcing fibers 39 inside them. There are one or more reinforcement fibers 39 in the valve leaflet of synthetic material, which start and end at two different joint points 332 or joint lines 331 of the same valve leaflet, and are connected to the support 10; the reinforcement fibers 39 can be located at the free edge 333 of the valve leaflet 33 , mainly on the downstream surface 340 of the valve leaflet, the aortic side 340 of the downstream surface of the valve leaflet is made into a linear wrinkled surface, and the upstream surface of the valve leaflet on the ventricular side 341 is a smooth surface. The material of the reinforcing fiber 39 includes polyester fiber, high molecular polyethylene fiber, nylon and carbon fiber and the like. The reinforcing fiber 39 can selectively strengthen the strength of the elastic synthetic material membrane, and can also strengthen the strength between the synthetic membrane and the support. Reinforcing fibers 39 may also be on radiopaque markers 311,312.

继续参见图1至图6,本发明人工心脏支架瓣膜1中设有柔性联结环41。在支架的末端开放式线拐102和密封式线眼103处,在支架的中部两末端之间二段编织线交错点107、107’处,可用涤纶、尼龙、聚酯、聚丙二醇等材料制成的软线构成柔性联结环41。细而软的软线首先结成一个环412,环的大小不同,线的长短不一。环412的另外一边的两线头在支架上打结环扎413与之联成一体,不能移动。输放装置拉线70可以从柔性联结环41中穿过,滑动,压缩支架。柔性联结环41用于限制拉线70的摆动范围并防止脱位。Continuing to refer to FIG. 1 to FIG. 6 , the artificial heart stent valve 1 of the present invention is provided with a flexible coupling ring 41 . At the end of the support, the open line turn 102 and the sealed line eye 103, at the intersection point 107, 107' of the two braided lines between the two ends of the middle of the support, can be made of polyester, nylon, polyester, polypropylene glycol and other materials. The formed flexible wire constitutes the flexible coupling ring 41. The thin and soft flexible wires are first formed into a ring 412, the rings are of different sizes, and the wires are of different lengths. The two thread ends on the other side of the ring 412 are tied into a knotted cerclage 413 on the support to be integrated with it and cannot move. The delivery device pull wire 70 can pass through the flexible coupling ring 41, slide, and compress the bracket. The flexible coupling ring 41 is used to limit the swing range of the pull wire 70 and prevent dislocation.

综上所述,本发明的人工心脏支架瓣膜具有以下的特点和优点:In summary, the artificial heart stent valve of the present invention has the following characteristics and advantages:

1、设有径向突凸出结构1531. There is a radial protrusion structure 153

支架瓣膜中部15的鼓形膨胀体152形状一改下游段13和上游段18的圆截面,可以分为一个或一个以上径向突出结构153。径向突出结构153为支架外表面上球壳面,抛物线曲面等形状的突出结构。支架瓣膜1上的径向突出结构153为支架10整体的一部分。可为同一编织单线104构成。理想为三个120度左右分配的半球形的径向突出结构153。三个径向突出结构153中部157x直径较大,有利于沿xx轴向和绕xx轴旋转方向起定位和固定作用。与中游段15为园桶形151的支架瓣膜1相反,径向突出结构153贴血管壁。同一平面上相邻的二个径向突出结构153在联合点160相连,构成瓣叶联合点332。两个相邻的径向突出结构在联合点160和瓣叶联合点332内收,外径较突出结构中部157x的外径小。这样工作状态下大直径支架有小直径瓣膜叶,但有足够的开口面积,使瓣膜叶张力下降;瓣膜叶33在瓣叶联合点332损伤减少;瓣膜叶33打开血液通过时接触不到支架10,使瓣膜叶不会因为与支架相碰撞而受磨损;瓣膜叶33厚度不变的情况下,瓣膜叶直径减少则体积减少,有利于径向压缩。半月形的上游周边159i构成与瓣膜叶33相连的瓣叶联合线331。虽然同一水平径向突出结构153的相邻可变形单元不等长,但编织支架交错点107上相邻段编织丝104之间的滑动,保证了支架和径向突出结构可以径向压缩,径向扩张。不在一个水平的上游段喇叭口182的上游端口184是与三个径向突出结构153相对应的三个波浪形边185。支架从上游端184到下游端134的编织丝104每段的长度一样。径向压缩、轴向延长时,交错点上相邻段线滑动,三个径向突出结构153和三波浪形185消失,上游端各可变形单元平行。有利于上游端184开放式线拐102和密封式线眼103与输放装置2的支架拉线配合。Once the shape of the drum-shaped expansion body 152 in the middle part 15 of the stent valve is changed to the circular section of the downstream section 13 and the upstream section 18 , it can be divided into one or more radially protruding structures 153 . The radial protruding structure 153 is a protruding structure in the shape of a spherical shell surface, a parabolic curved surface, or the like on the outer surface of the bracket. The radial protruding structure 153 on the stent valve 1 is an integral part of the stent 10 . It may be composed of the same braided single wire 104 . Ideally, there are three hemispherical radially protruding structures 153 distributed about 120 degrees. The middle part 157x of the three radially protruding structures 153 has a larger diameter, which is beneficial for positioning and fixing along the xx axis and the rotation direction around the xx axis. Contrary to the stent-valve 1 in which the middle section 15 has a barrel shape 151, the radially protruding structure 153 sticks to the vessel wall. Two adjacent radially protruding structures 153 on the same plane are connected at the joint point 160 to form the leaflet joint point 332 . Two adjacent radial protruding structures are adducted at the joint point 160 and the leaflet joint point 332, and the outer diameter is smaller than that of the central part 157x of the protruding structure. In this way, the large-diameter stent has small-diameter valve leaflets in the working state, but there is enough opening area to reduce the tension of the valve leaflets; the damage of the valve leaflets 33 at the joint point 332 of the valve leaflets is reduced; the valve leaflets 33 cannot touch the stent 10 when the blood passes through. , so that the valve leaflets will not be worn due to collision with the stent; when the thickness of the valve leaflets 33 remains the same, the volume of the valve leaflets decreases when the diameter of the valve leaflets decreases, which is beneficial to radial compression. The upstream perimeter 159i of the half-moon forms the leaflet commissure line 331 connecting the valve leaflets 33 . Although adjacent deformable units of the same horizontal radially protruding structure 153 have unequal lengths, the sliding between adjacent sections of braided wire 104 on the braided stent intersecting point 107 ensures that the stent and the radially protruding structure can be compressed radially. to expand. The upstream port 184 of the bell mouth 182 of the upstream section that is not in one level is three wavy sides 185 corresponding to the three radially protruding structures 153 . Each segment of the braided wire 104 is the same length from the upstream end 184 to the downstream end 134 of the stent. When radially compressed and axially extended, the adjacent segments at the intersection point slide, the three radially protruding structures 153 and the three wavy shapes 185 disappear, and the deformable units at the upstream end are parallel. It is beneficial for the upstream end 184 to cooperate with the support pull wire of the open type wire turn 102 and the sealed type wire eye 103 of the delivery device 2 .

2、可设有外层环状结构1552. An outer ring structure 155 can be provided

外层环状结构155不密封膜,让血液通过。外层环状结构155与输放装置2上特定的支架拉线配合,可先于支架体154单独释放。扩张的外层环状结构155有定位和固定作用。The outer ring structure 155 does not seal the membrane and allows blood to pass through. The outer ring structure 155 cooperates with the specific support pull wire on the delivery device 2 and can be released separately before the support body 154 . The expanded outer ring structure 155 has positioning and fixing functions.

3、可设有外层游离舌1563. An outer free tongue 156 can be provided

外层游离舌156不密封膜,让血液通过。外层游离舌156与输放装置2上特定的支架拉线配合,可先于支架体154单独释放。扩张的外层游离舌156有定位和固定作用。外层游离舌156的联合点165与瓣叶联合点332可有确定的旋转关系,如在同一旋转平面上。The outer free tongue 156 is membrane-free and allows blood to pass. The outer free tongue 156 cooperates with the specific support backguy on the delivery device 2, and can be released separately prior to the support body 154. The expanded outer free tongue 156 has positioning and fixing functions. The joint point 165 of the outer free tongue 156 and the leaflet joint point 332 may have a definite rotational relationship, such as being on the same rotational plane.

4、网状支架10可由单个弹性编织线104编织构成4. The mesh support 10 can be composed of a single elastic braided wire 104

无论是什么外形的自扩张型支架10均可由单个弹性编织线104编织而成。一个单线构成的支架,整体性强,力学上更结实,而不需各线间焊接。单个线起点105和终点106可相连焊接或重叠。单线支架的编织线两头105、106均在支架下游段13和中游段15间。两个头105、106可朝一个方向,向上游端,或下游端。单个弹性编织线104可以绕成开放式线拐102和密封式线眼103。密封式线眼103可以与支架在同一外轮廓曲面上或切面上,也可以在与支架相垂直的平面上(径面上)向内或向外,也可以在这二者之间。对于三瓣膜叶支架瓣膜来说,沿周长的可变形单元数CN为三的倍数有利于三瓣膜叶对称。由单个编织线104编织的支架10的沿周长可变形单元数CN除以沿长轴可变形单元数LN应该是一个分数而不是一个整数。同一根单线104可以在网状支架10上构成径向突出结构153。交错点107、107’上相邻段编织线之间的滑动,保证了支架和径向突出结构153可以径向压缩,径向扩张。同一根单线104可以在编织支架10的同一位置两次或多次重复重叠。同一根单线104可以在编织支架10的局部或全部重复,还可以编织成支架的外层环状结构155或外层游离舌156。No matter what shape the self-expanding stent 10 can be braided from a single elastic braided wire 104 . A bracket composed of a single wire has strong integrity and is stronger mechanically without welding between wires. Individual line start points 105 and end points 106 may be welded together or overlapped. Both ends 105 and 106 of the braided wire of the single-wire stent are located between the downstream section 13 and the midstream section 15 of the stent. The two heads 105, 106 can face in one direction, toward the upstream end, or toward the downstream end. A single elastic braid 104 can be wound into open loops 102 and sealed eyes 103 . The sealed wire eye 103 can be on the same outer contour curved surface or tangent plane with the bracket, or can be inward or outward on a plane (diameter plane) perpendicular to the bracket, or can be in between. For a three-valve leaflet stent valve, the number of deformable units CN along the circumference is a multiple of three, which is beneficial to the symmetry of the three valve leaflets. The number CN of deformable units along the perimeter of the stent 10 woven by a single braided wire 104 divided by the number LN of deformable units along the long axis should be a fraction rather than an integer. The same single wire 104 can form the radially protruding structure 153 on the mesh stent 10 . The sliding between adjacent sections of braided wires at the intersection points 107, 107' ensures that the stent and the radially protruding structure 153 can be radially compressed and radially expanded. The same single wire 104 can overlap two or more times at the same position of the braided stent 10 . The same single wire 104 can be repeated in part or all of the braided stent 10 , and can also be braided into the outer ring structure 155 or the outer free tongue 156 of the stent.

5、可设有密封环375. A sealing ring 37 can be provided

支架瓣膜扩张后顶着血管壁,管状密封环37可被压缩使其适应,填补支架与血管壁之间的缝隙。After the stent valve expands, it bears against the blood vessel wall, and the tubular sealing ring 37 can be compressed to adapt to fill the gap between the stent and the blood vessel wall.

6、支架瓣膜1上游端可设有喇叭开口6. The upstream end of the stent valve 1 can be provided with a horn opening

喇叭形182上游段18的上游端口184是与三个径向突出结构153相对应的三叶波浪形口185。上游段密封膜351可以在支架以外向上游方向延伸构成没有支架支承的软膜352。The upstream port 184 of the upstream section 18 of the trumpet shape 182 is a three-lobed wave-shaped mouth 185 corresponding to the three radially protruding structures 153 . The sealing membrane 351 of the upstream section may extend outside the stent in the upstream direction to form a soft membrane 352 not supported by the stent.

7、设有不透X线标志311、3127. There are X-ray opaque signs 311, 312

不透X线标志311可位于支架瓣膜的上游端,下游端和瓣膜叶结合点。编织支架单线或重叠的多线段外镶有不透X线的环管。不透X线的环管可作为X线标志定位;防止同一位置上的两根线或多线脱位;保护编织线头105、106不损伤组织。The radiopaque markers 311 can be located at the upstream end, the downstream end and the junction of the valve leaflets of the stent-valve. The braided stent has a single wire or overlapping multiple wire segments surrounded by a radiopaque ring tube. The X-ray-opaque ring tube can be used as an X-ray marker for positioning; prevent dislocation of two or more wires at the same position; and protect the braided wire ends 105, 106 from damaging tissues.

8、支架瓣膜1如果由弹性合成材料构成瓣膜叶33、密封膜351、354和密封环37可同时具有下列四种功能:8. If the stent valve 1 is made of elastic synthetic material, the valve leaflets 33, sealing membranes 351, 354 and sealing ring 37 can have the following four functions at the same time:

a、瓣膜叶33防返流,密封膜351、354和密封环37防漏屏障的基本功能。a. The valve leaflets 33 prevent reflux, the basic functions of the sealing membranes 351, 354 and the sealing ring 37 as a leak-proof barrier.

b、支架瓣膜1的弹性变形好b. The elastic deformation of the stent valve 1 is good

自扩张支架编织线104交叉后构成四边形可变形单元101。二线交叉点107上涂层或四边形之间覆盖有弹性合成材料膜351、354。支架和膜二者均为弹性材料,在径向压缩力作用下一齐弹性变形。四边形可变形单元101在xx轴向延长,四边形可变形单元101内覆盖膜在xx轴向弹性延长。与血管壁相对抗的平衡状态下或工作状态下的支架瓣膜,其支架上密封膜351、354和弹性合成材料面层没有恢复到原来的长度和形状前,弹性合成材料膜弹性变形的回弹力增加了支架瓣膜的径向膨胀力和轴向回弹力。由弹性材料制成的瓣膜叶及密封膜,在支架瓣膜释放后,可以通过球囊超级扩张,而支架瓣膜仍为弹性变形不至受损伤。The quadrilateral deformable unit 101 is formed after the braided wires 104 of the self-expanding stent intersect. The coating on the intersection 107 of the two lines or between the quadrilaterals is covered with a film 351, 354 of elastic synthetic material. Both the scaffold and the membrane are elastic materials that deform elastically together under radial compressive forces. The quadrilateral deformable unit 101 is extended along the xx axis, and the covering film inside the quadrilateral deformable unit 101 is elastically extended along the xx axis. The stent valve in the equilibrium state against the vessel wall or in the working state, before the sealing membranes 351, 354 and the elastic synthetic material surface layer on the stent return to the original length and shape, the resilience of the elastic synthetic material membrane elastic deformation The radial expansion force and axial rebound force of the stent valve are increased. The valve leaflets and sealing membrane made of elastic materials can be super-expanded by the balloon after the stent valve is released, while the stent valve is still elastically deformed without being damaged.

c、弹性合成材料包在金属支架线上,防止血管上皮细胞长在金属支架线上,使人工支架瓣膜不与血管壁粘连,以备再取出。c. The elastic synthetic material is wrapped on the metal stent wire to prevent the vascular epithelial cells from growing on the metal stent wire, so that the artificial stent valve is not adhered to the blood vessel wall and is ready to be taken out again.

D、与生物瓣膜叶不同,合成瓣膜叶和密封膜可以耐低温0℃以下,不会为运输,特别是空运提出特别条件。在装配和压缩前,如Nitinol镍钛形状记忆合金支架瓣膜温度降到Af以下,镍钛合金从Austenitic状态变成Martensitic状态,材料变软,弹性消失,有利于径向压缩。进入体内后,加温37℃,镍钛记忆合金恢复Austenitic状态,回到超级弹性状态。D. Unlike biological valve leaflets, synthetic valve leaflets and sealing membranes can withstand low temperatures below 0°C, and will not impose special conditions for transportation, especially air transportation. Before assembly and compression, if the temperature of the Nitinol nickel-titanium shape memory alloy stent valve drops below Af, the nickel-titanium alloy changes from the Austenitic state to the Martensitic state, and the material becomes soft and the elasticity disappears, which is conducive to radial compression. After entering the body, heated to 37°C, the nickel-titanium memory alloy returns to the Austenitic state and returns to the super elastic state.

9、设有加强纤维399. Equipped with reinforcing fiber 39

支架瓣膜1中的加强纤维39有方向选择性地提高了弹性合成材料瓣膜叶33和密封膜351、354的强度,减少其被撕裂的可能性。合成支架瓣膜1中的加强纤维39使合成瓣膜叶33环形加固,不妨碍瓣膜叶开关;合成瓣膜叶33游离边缘加固,防止其撕裂;合成瓣膜叶33与支架交结处联合点和联合线加固,使交结处变结实,不被撕裂;使交结处变圆滑,减少血栓形成;密封膜351、354和支架10间加固;编织线交叉点107上两线绑上固定。The reinforcing fibers 39 in the stent valve 1 selectively increase the strength of the elastic synthetic material valve leaflets 33 and the sealing membranes 351, 354, reducing the possibility of them being torn. The reinforcing fiber 39 in the synthetic stent valve 1 makes the synthetic valve leaflet 33 annularly reinforced, without hindering the opening and closing of the valve leaflet; the free edge of the synthetic valve leaflet 33 is reinforced to prevent it from tearing; the joint point and joint line of the synthetic valve leaflet 33 and the stent are reinforced , so that the joints become strong and not torn; the joints are smoothed to reduce thrombus formation; the sealing membranes 351, 354 and the bracket 10 are reinforced; the two lines on the braided line intersection 107 are tied and fixed.

10、支架瓣膜1的开放式线拐102、封闭式线眼103的作用和与输放装置的支架拉线合作:使开放式线拐102和密封式线眼103增加径向弹力,减少材料变形;弹性合成膜内的加强纤维可以固定在开放式线拐102和密封式线眼103上面;密封式线眼103可以固定瓣膜叶的联合点332。如果密封式线眼103向内侧转90度角并与切面垂直,它可以使联合点332内移,瓣膜叶张力下降;开放式线拐102和密封式线眼103用于与输放装置的支架拉线配合,将支架瓣膜1临时固定,压缩在输放装置的内管51上。支架拉线如从密封式线眼103穿过,它将不会滑脱和移动。10. The function of the open wire bend 102 and the closed wire eye 103 of the stent valve 1 and the cooperation with the stent pull wire of the delivery device: the open wire bend 102 and the sealed wire eye 103 increase radial elasticity and reduce material deformation; Reinforcing fibers in the elastic synthetic membrane can be fixed over the open crutches 102 and sealed eyelets 103; the sealed eyelets 103 can fix the commissure points 332 of the valve leaflets. If the sealed wire eye 103 is turned 90 degrees to the inside and is perpendicular to the incision plane, it can move the joint point 332 inward, and the valve leaflet tension decreases; the open wire crutch 102 and the sealed wire eye 103 are used for the support of the delivery device The pull wire cooperates to temporarily fix the stent valve 1 and compress it on the inner tube 51 of the delivery device. If the support backguy passes through the sealed eyelet 103, it will not slip off and move.

11、设有柔性联结环4111. There is a flexible coupling ring 41

支架拉线如从支架瓣膜1上的柔性联结环41穿过,它将不会滑脱和移动。If the stent backguy passes through the flexible coupling ring 41 on the stent valve 1, it will not slip off and move.

Claims (27)

1.一种人工心脏支架瓣膜,其特征在于:包括一个可以在扩张状态和压缩状态之间径向变形的管形网状支架,该网状支架包括上游段、中段和下游段,网状支架各网线之间构成或围成多个可变形单元,在网状支架的两端形成多个开放式线拐,并设有与可变形单元分开的密封式线眼,在网状支架中段的内侧连接有可以开关并让血液单向通过的瓣膜叶,瓣膜叶与网状支架相结合处构成瓣叶联合线,二个相邻的瓣膜叶的瓣叶联合线相交构成瓣叶联合点,在网状支架上游段的内侧和/或外侧面上覆盖有密封膜并延伸至中段,在网状支架上设有多个不透X线标志和柔性联结环,所述密封膜由生物材料构成。1. an artificial heart stent valve, is characterized in that: comprise a tubular mesh support that can radially deform between expansion state and compression state, this mesh support comprises upstream section, middle section and downstream section, mesh support A plurality of deformable units are formed or surrounded by each network cable, and a plurality of open wire bends are formed at both ends of the mesh support, and a sealed wire eye separate from the deformable unit is provided, inside the middle section of the mesh support It is connected with valve leaflets that can be switched on and off and allow blood to pass through in one direction. The junction of the valve leaflets and the mesh stent forms the leaflet joint line, and the intersection of the leaflet joint lines of two adjacent valve leaflets forms the leaflet joint point. The inner side and/or outer side of the upstream section of the mesh stent are covered with a sealing film and extend to the middle section. A plurality of X-ray-opaque signs and flexible coupling rings are arranged on the mesh stent, and the sealing film is made of biological materials. 2.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的网状支架由弹性线材编织而成,或由弹性管材切割而成。2. The artificial heart stent valve according to claim 1, characterized in that: the mesh stent is woven from elastic wires or cut from elastic tubing. 3.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的网状支架整体呈大小一致的圆管形,在圆管形网状支架的中段设有支架开口。3. artificial heart stent valve as claimed in claim 1, is characterized in that: described mesh stent overall is the circular tube shape of uniform size, is provided with support opening in the middle section of circular tube shape mesh stent. 4.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的网状支架的中段呈向外突出的鼓形,在鼓形中段的中部设有支架开口。4. The artificial heart stent valve according to claim 1, characterized in that: the middle section of the mesh stent is in the shape of a drum protruding outward, and a bracket opening is provided in the middle of the drum-shaped middle section. 5.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的网状支架的中段在圆管形或轻微鼓形的基础上变形出至少一个向外突出的径向突出结构,在每个径向突出结构的中心设有一个较大的支架开口,径向突出结构与网状支架本体相连处形成一个半月形的上游周边和一个半月形的下游周边,半月形的上游周边构成与瓣膜叶相连的瓣叶联合线。5. artificial heart stent valve as claimed in claim 1, it is characterized in that: the middle section of described mesh support deforms at least one outwardly protruding radially protruding structure on the basis of circular tube shape or slight drum shape, A large bracket opening is provided in the center of each radially protruding structure. The connection between the radially protruding structure and the mesh bracket body forms a half-moon-shaped upstream periphery and a half-moon-shaped downstream periphery. The half-moon-shaped upstream periphery constitutes Leaflet commissure line connecting the valve leaflets. 6.如权利要求5所述的人工心脏支架瓣膜,其特征在于:所述的网状支架中段的径向突出结构为一个。6. The artificial heart stent valve according to claim 5, characterized in that: the radially protruding structure of the middle section of the mesh stent is one. 7.如权利要求5所述的人工心脏支架瓣膜,其特征在于:所述的网状支架中段的径向突出结构为两个,两个径向突出结构为90-180度转角分配。7. The artificial heart stent valve as claimed in claim 5, characterized in that: there are two radially protruding structures in the middle section of the mesh stent, and the two radially protruding structures are distributed at a 90-180 degree rotation angle. 8.如权利要求5所述的人工心脏支架瓣膜,其特征在于:所述的网状支架中段的径向突出结构为三个,三个径向突出结构沿径向均匀分配。8. The artificial heart stent valve according to claim 5, characterized in that: there are three radially protruding structures in the middle section of the mesh stent, and the three radially protruding structures are evenly distributed along the radial direction. 9.如权利要求5所述的人工心脏支架瓣膜,其特征在于:所述的网状支架的上游段呈喇叭形,喇叭形上游段的外缘设有与中段的径向突出结构相对应的波浪形口边。9. artificial heart stent valve as claimed in claim 5, it is characterized in that: the upstream section of described reticular support is trumpet-shaped, and the outer edge of trumpet-shaped upstream section is provided with the radial protruding structure corresponding with middle section Wavy lip. 10.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的网状支架的中段为圆管形内外双层结构,在支架本体上连接有一个外层环状结构,外层环状结构与内层在下游段或下游段与中段的交界处相连形成固定缘,外层环状结构止于上游段与中段的交界处形成游离缘并设有密封式线眼与可变形单元分开。10. artificial heart stent valve as claimed in claim 1, is characterized in that: the middle section of described reticular support is circular tube shape inside and outside double-layer structure, is connected with an outer layer annular structure on support body, outer layer The annular structure and the inner layer are connected at the downstream section or the junction of the downstream section and the middle section to form a fixed edge, and the outer annular structure ends at the junction of the upstream section and the middle section to form a free edge and is equipped with a sealed line eye and a deformable unit separate. 11.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的网状支架的中段以圆管形或轻微鼓形为内层,外侧连接有至少一个由单根网线围合而成的游离舌外层,所述的游离舌与内层支架体在下游段或下游段与中段的交界处相连形成固定缘,并从固定缘开始向上游段延伸至上游段与中段的交界处形成游离缘,游离缘前端设有密封式线眼,线眼上套有不透X线标志。11. artificial heart stent valve as claimed in claim 1, is characterized in that: the middle section of described mesh stent is inner layer with circular tube shape or slight drum shape, and the outside is connected with at least one by a single mesh wire. The outer layer of the formed free tongue, the free tongue and the inner support body are connected at the downstream section or the junction of the downstream section and the middle section to form a fixed edge, and extend from the fixed edge to the upstream section to the junction of the upstream section and the middle section A free edge is formed, and the front end of the free edge is provided with a sealed line eye, and an X-ray-opaque mark is set on the line eye. 12.如权利要求11所述的人工心脏支架瓣膜,其特征在于:所述的游离舌为三个,三个游离舌以120度转角分配,并与瓣膜叶相对应。12. artificial heart stent valve as claimed in claim 11 is characterized in that: described free tongue is three, and three free tongues are distributed with 120 degree rotation angle, and correspond to valve leaflet. 13.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的网状支架的中段在圆管形或轻微鼓形的基础上变形出至少一个向外突出的径向突出结构,在各径向突出结构上连接有由单根网线围合而成的游离舌,游离舌的游离缘与径向突出结构的半月形的上游周边在两个平行的曲面上重叠,或者游离舌的游离缘与径向突出结构的周边在两个平行的曲面上重叠。13. artificial heart stent valve as claimed in claim 1, is characterized in that: the middle section of described mesh stent deforms at least one outwardly protruding radially protruding structure on the basis of circular tube shape or slight drum shape, Each radial protruding structure is connected with a free tongue surrounded by a single mesh wire, and the free edge of the free tongue overlaps with the half-moon upstream periphery of the radial protruding structure on two parallel curved surfaces, or the free tongue The free edge overlaps the perimeter of the radially protruding structure on two parallel curved surfaces. 14.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的瓣膜叶由生物材料构成。14. The artificial heart stent valve according to claim 1, wherein the valve leaflets are made of biological materials. 15.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的瓣膜叶由合成材料构成,在合成材料瓣膜叶内设有至少一条加强纤维,该加强纤维起止于同一瓣膜叶的两个不同的联合点或联合线,连接在网状支架上。15. artificial heart stent valve as claimed in claim 1, is characterized in that: described valve leaflet is made of synthetic material, is provided with at least one reinforcing fiber in synthetic material valve leaflet, and this reinforcing fiber starts and ends at the same valve leaflet Two distinct joint points or joint lines, connected on a mesh support. 16.如权利要求15所述的人工心脏支架瓣膜,其特征在于:所述的加强纤维设置在瓣膜叶的下游面,或设置在瓣膜叶的游离边或关闭边。16. The artificial heart stent valve according to claim 15, characterized in that: said reinforcing fiber is arranged on the downstream surface of the valve leaflet, or arranged on the free edge or closing edge of the valve leaflet. 17.如权利要求1、14或15所述的人工心脏支架瓣膜,其特征在于:所述的瓣膜叶为二个,每个瓣膜叶包括游离边和关闭边,游离边和关闭边之间形成关闭区。17. artificial heart stent valve as claimed in claim 1,14 or 15, is characterized in that: described valve leaflet is two, and each valve leaflet comprises free edge and closing edge, forms between free edge and closing edge closed area. 18.如权利要求1、14或15所述的人工心脏支架瓣膜,其特征在于:所述的瓣膜叶为三个,每个瓣膜叶包括游离边和关闭边,游离边和关闭边之间形成关闭区,所述三个瓣膜叶呈120度转角分配。18. artificial heart stent valve as claimed in claim 1,14 or 15, is characterized in that: described valve leaflet is three, and each valve leaflet comprises free edge and closing edge, forms between free edge and closing edge In the closed area, the three valve leaflets are distributed at a 120-degree rotation angle. 19.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的密封膜在网状支架的密封式线眼处相应设有内外相通的密封膜眼。19. The artificial heart stent valve according to claim 1, characterized in that: said sealing membrane is provided with a sealing membrane eye communicating with the inside and outside at the sealing line eye of the mesh stent. 20.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的密封膜在网状支架以外向上游方向延伸构成没有支架支承的软膜,在网状支架以内向下游方向延伸到瓣叶联合线。20. artificial heart stent valve as claimed in claim 1, is characterized in that: described sealing membrane is extended to the pia mater that does not have stent support outside mesh stent in upstream direction, extends to downstream direction in mesh stent Leaflet joint line. 21.如权利要求15所述的人工心脏支架瓣膜,其特征在于:所述加强纤维选自涤纶纤维、丙纶纤维、聚乙烯纤维或碳纤维。21. The artificial heart stent valve according to claim 15, wherein the reinforcing fiber is selected from polyester fiber, polypropylene fiber, polyethylene fiber or carbon fiber. 22.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的不透X线标志为套装在网线上的管形点状标志,该管形点状标志设置在网状支架中段的瓣叶联合点,或设置在网状支架的上游段或上游段与中段的交界处或下游段。22. The artificial heart stent valve according to claim 1, characterized in that: said X-ray-opaque mark is a tubular point-shaped mark set on a mesh wire, and the tubular point-shaped mark is arranged in the middle section of the mesh stent The joint point of the valve leaflets, or set at the upstream section of the mesh stent or at the junction of the upstream section and the middle section or at the downstream section. 23.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的不透X线标志为头尾相连的线状标志,该线状标志相邻于瓣叶联合线交织在网状支架的网线上。23. The artificial heart stent valve according to claim 1, characterized in that: the radio-opaque markers are linear markers connected head to tail, and the linear markers are interwoven in a mesh shape adjacent to the joint line of the leaflets. network cable on the stand. 24.如权利要求1所述的人工心脏支架瓣膜,其特征在于:所述的柔性联结环设置在网状支架两端的开放式线拐和密封式线眼处以及网状支架的中部。24. The artificial heart stent valve according to claim 1, characterized in that: said flexible coupling rings are arranged at the open wire turns and sealed wire eyes at both ends of the mesh stent and at the middle of the mesh stent. 25.如权利要求1所述的人工心脏支架瓣膜,其特征在于:还包括密封环,该密封环设置在网状支架的上游段与中段交界处的外侧,所述的密封环为柔软的半开放式管状结构,呈圆环形或与径向突出结构相对应的波浪形,其上设有多个点状开口朝向支架瓣膜的内面或外面,或设有槽状开口朝向支架瓣膜的内面。25. artificial heart stent valve as claimed in claim 1, it is characterized in that: also comprise seal ring, this seal ring is arranged on the outside of the upstream section and middle section junction of mesh support, and described seal ring is soft half The open tubular structure is circular or wavy corresponding to the radially protruding structure, and is provided with a plurality of point-shaped openings facing the inner or outer surface of the stent valve, or provided with slot-shaped openings facing the inner surface of the stent valve. 26.如权利要求25所述的人工心脏支架瓣膜,其特征在于:所述的密封环由生物材料构成。26. The artificial heart stent valve as claimed in claim 25, wherein the sealing ring is made of biological material. 27.如权利要求25所述的人工心脏支架瓣膜,其特征在于:所述的密封环由合成材料构成。27. The artificial heart stent valve as claimed in claim 25, wherein the sealing ring is made of synthetic material.
CN200510110145A 2005-11-09 2005-11-09 Artificial heart stent valve Expired - Lifetime CN100584292C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200510110145A CN100584292C (en) 2005-11-09 2005-11-09 Artificial heart stent valve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200510110145A CN100584292C (en) 2005-11-09 2005-11-09 Artificial heart stent valve

Publications (2)

Publication Number Publication Date
CN1961845A CN1961845A (en) 2007-05-16
CN100584292C true CN100584292C (en) 2010-01-27

Family

ID=38081188

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200510110145A Expired - Lifetime CN100584292C (en) 2005-11-09 2005-11-09 Artificial heart stent valve

Country Status (1)

Country Link
CN (1) CN100584292C (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
US11166814B2 (en) 2019-08-20 2021-11-09 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
US11202706B2 (en) 2019-05-04 2021-12-21 Vdyne, Inc. Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US11273033B2 (en) 2018-09-20 2022-03-15 Vdyne, Inc. Side-delivered transcatheter heart valve replacement
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US11298227B2 (en) 2019-03-05 2022-04-12 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
US11331186B2 (en) 2019-08-26 2022-05-17 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11786366B2 (en) 2018-04-04 2023-10-17 Vdyne, Inc. Devices and methods for anchoring transcatheter heart valve
US12186187B2 (en) 2018-09-20 2025-01-07 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US12343256B2 (en) 2019-01-10 2025-07-01 Vdyne, Inc. Anchor hook for side-delivery transcatheter heart valve prosthesis

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101172059B (en) * 2006-10-31 2010-12-08 温宁 Bracket valve with internal layer ligule structure and method for knitting bracket
CN101091675B (en) * 2007-07-19 2010-06-16 中国人民解放军第二军医大学 Double disc atrioventricular valve stent with prosthetic valve
DE102007043830A1 (en) 2007-09-13 2009-04-02 Lozonschi, Lucian, Madison Heart valve stent
CN101450018B (en) * 2007-11-28 2010-09-08 王涛 Recoverable valve bracket
EP2254512B1 (en) * 2008-01-24 2016-01-06 Medtronic, Inc. Markers for prosthetic heart valves
US8308798B2 (en) * 2008-12-19 2012-11-13 Edwards Lifesciences Corporation Quick-connect prosthetic heart valve and methods
CA2783282C (en) 2009-12-08 2018-04-03 Avalon Medical Ltd. Device and system for transcatheter mitral valve replacement
CN102113921A (en) 2009-12-30 2011-07-06 微创医疗器械(上海)有限公司 Intervention-type heart valve
CN102125475A (en) * 2011-01-24 2011-07-20 中国人民解放军第二军医大学 Combined ascending aortic intracavitary isolation implant
US8945209B2 (en) * 2011-05-20 2015-02-03 Edwards Lifesciences Corporation Encapsulated heart valve
EP3964176B1 (en) 2011-06-21 2025-05-14 Twelve, Inc. Prosthetic heart valve devices
WO2013028387A2 (en) 2011-08-11 2013-02-28 Tendyne Holdings, Inc. Improvements for prosthetic valves and related inventions
US9039757B2 (en) 2011-10-19 2015-05-26 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
CA2848334C (en) 2011-10-19 2020-10-20 Twelve, Inc. Devices, systems and methods for heart valve replacement
US11202704B2 (en) 2011-10-19 2021-12-21 Twelve, Inc. Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods
EA201400481A1 (en) * 2011-10-19 2014-10-30 Твелв, Инк. ARTIFICIAL HEART VALVE DEVICES, ARTIFICIAL MITRAL VALVES AND RELATED SYSTEMS AND METHODS
US9827092B2 (en) 2011-12-16 2017-11-28 Tendyne Holdings, Inc. Tethers for prosthetic mitral valve
US9700399B2 (en) 2012-04-26 2017-07-11 Medtronic Vascular, Inc. Stopper to prevent graft material slippage in a closed web stent-graft
CN102670332B (en) * 2012-05-24 2016-08-03 沛嘉医疗科技(上海)有限公司 A kind of novel artificial heart valve
WO2014022124A1 (en) 2012-07-28 2014-02-06 Tendyne Holdings, Inc. Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly
US9675454B2 (en) 2012-07-30 2017-06-13 Tendyne Holdings, Inc. Delivery systems and methods for transcatheter prosthetic valves
US9968443B2 (en) * 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
BR112015022526B1 (en) * 2013-03-15 2020-12-15 Symetis Sa STENT VALVE FOR TRANSCATETER IMPLANT FOR REPLACEMENT OF A HEART VALVE
US10463489B2 (en) 2013-04-02 2019-11-05 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US11224510B2 (en) 2013-04-02 2022-01-18 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US10478293B2 (en) 2013-04-04 2019-11-19 Tendyne Holdings, Inc. Retrieval and repositioning system for prosthetic heart valve
US9610159B2 (en) 2013-05-30 2017-04-04 Tendyne Holdings, Inc. Structural members for prosthetic mitral valves
US20140358224A1 (en) * 2013-05-30 2014-12-04 Tendyne Holdlings, Inc. Six cell inner stent device for prosthetic mitral valves
CA2914856C (en) 2013-06-25 2021-03-09 Chad Perrin Thrombus management and structural compliance features for prosthetic heart valves
WO2015017689A1 (en) 2013-08-01 2015-02-05 Robert Vidlund Epicardial anchor devices and methods
WO2015058039A1 (en) 2013-10-17 2015-04-23 Robert Vidlund Apparatus and methods for alignment and deployment of intracardiac devices
CA2924389C (en) 2013-10-28 2021-11-09 Tendyne Holdings, Inc. Prosthetic heart valve and systems and methods for delivering the same
US9526611B2 (en) 2013-10-29 2016-12-27 Tendyne Holdings, Inc. Apparatus and methods for delivery of transcatheter prosthetic valves
WO2016112085A2 (en) 2015-01-07 2016-07-14 Mark Christianson Prosthetic mitral valves and apparatus and methods for delivery of same
WO2015120122A2 (en) 2014-02-05 2015-08-13 Robert Vidlund Apparatus and methods for transfemoral delivery of prosthetic mitral valve
US9986993B2 (en) 2014-02-11 2018-06-05 Tendyne Holdings, Inc. Adjustable tether and epicardial pad system for prosthetic heart valve
SG11201606836TA (en) * 2014-02-20 2016-09-29 Mitral Valve Technologies Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
JP6865037B2 (en) 2014-03-10 2021-04-28 テンダイン ホールディングス,インコーポレイテッド Devices and methods for positioning the artificial mitral valve and monitoring the tether load of the artificial mitral valve
US10195025B2 (en) * 2014-05-12 2019-02-05 Edwards Lifesciences Corporation Prosthetic heart valve
ES2676060T3 (en) * 2014-09-26 2018-07-16 Nvt Ag Implantable device for the treatment of mitral valve regurgitation
ES2877699T3 (en) 2015-02-05 2021-11-17 Tendyne Holdings Inc Prosthetic Heart Valve with Ligation and Expandable Epicardial Pad
CN107750150B (en) 2015-04-16 2021-03-05 坦迪尼控股股份有限公司 Devices and methods for delivering, repositioning and retrieving transcatheter prosthetic valves
US10327894B2 (en) 2015-09-18 2019-06-25 Tendyne Holdings, Inc. Methods for delivery of prosthetic mitral valves
CN108430391B (en) 2015-12-03 2020-09-08 坦迪尼控股股份有限公司 Frame Features for Prosthetic Mitral Valves
EP3397206B1 (en) 2015-12-28 2022-06-08 Tendyne Holdings, Inc. Atrial pocket closures for prosthetic heart valves
US10470877B2 (en) 2016-05-03 2019-11-12 Tendyne Holdings, Inc. Apparatus and methods for anterior valve leaflet management
EP3468480B1 (en) 2016-06-13 2023-01-11 Tendyne Holdings, Inc. Sequential delivery of two-part prosthetic mitral valve
CN109640887B (en) 2016-06-30 2021-03-16 坦迪尼控股股份有限公司 Prosthetic heart valve and device and method for delivering the same
US11065116B2 (en) 2016-07-12 2021-07-20 Tendyne Holdings, Inc. Apparatus and methods for trans-septal retrieval of prosthetic heart valves
CN108245281A (en) * 2016-12-28 2018-07-06 上海微创心通医疗科技有限公司 Valve prosthesis
EP3372198B1 (en) * 2017-03-06 2019-06-19 AVVie GmbH Implant for improving coaptation of an atrioventricular valve
WO2019014473A1 (en) 2017-07-13 2019-01-17 Tendyne Holdings, Inc. Prosthetic heart valves and apparatus and methods for delivery of same
WO2019046099A1 (en) 2017-08-28 2019-03-07 Tendyne Holdings, Inc. Prosthetic heart valves with tether coupling features
US11648110B2 (en) 2019-12-05 2023-05-16 Tendyne Holdings, Inc. Braided anchor for mitral valve
US11648114B2 (en) 2019-12-20 2023-05-16 Tendyne Holdings, Inc. Distally loaded sheath and loading funnel
US11951002B2 (en) 2020-03-30 2024-04-09 Tendyne Holdings, Inc. Apparatus and methods for valve and tether fixation
WO2022039853A1 (en) 2020-08-19 2022-02-24 Tendyne Holdings, Inc. Fully-transseptal apical pad with pulley for tensioning
CN112107393A (en) * 2020-10-22 2020-12-22 中国医学科学院阜外医院 Novel split type absorbable artificial intervention heart valve system

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11786366B2 (en) 2018-04-04 2023-10-17 Vdyne, Inc. Devices and methods for anchoring transcatheter heart valve
US11273033B2 (en) 2018-09-20 2022-03-15 Vdyne, Inc. Side-delivered transcatheter heart valve replacement
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US12186187B2 (en) 2018-09-20 2025-01-07 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US12343256B2 (en) 2019-01-10 2025-07-01 Vdyne, Inc. Anchor hook for side-delivery transcatheter heart valve prosthesis
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11298227B2 (en) 2019-03-05 2022-04-12 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
US11202706B2 (en) 2019-05-04 2021-12-21 Vdyne, Inc. Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus
US11179239B2 (en) 2019-08-20 2021-11-23 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
US11166814B2 (en) 2019-08-20 2021-11-09 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
US11331186B2 (en) 2019-08-26 2022-05-17 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery

Also Published As

Publication number Publication date
CN1961845A (en) 2007-05-16

Similar Documents

Publication Publication Date Title
CN100584292C (en) Artificial heart stent valve
US20250195210A1 (en) Valve anchor and installation method
US11471279B2 (en) Systems for rapidly deployable surgical heart valves
US20080275540A1 (en) Artificial Heart Valve Stent and Weaving Method Thereof
JP6990722B2 (en) Mitral valve prosthesis
EP2967852B1 (en) Anti-paravalvular leakage component for a transcatheter valve prosthesis
JP6473682B2 (en) Implantable device for treating heart valve regurgitation
US20220110743A1 (en) Collapsible-expandable heart valves
US10070954B2 (en) Mitral heart valve replacement
CN104394803B (en) Heart valve prosthesis
US9931207B2 (en) Methods of implanting a heart valve at an aortic annulus
US9370418B2 (en) Rapidly deployable surgical heart valves
CA2900655C (en) Rapidly deployable surgical heart valves
CN101686859B (en) Inwardly-bowed tricuspid annuloplasty ring
CN103153232B (en) There is the mitral of low ventricle profile
JP2021090836A (en) Heart valve prostheses having multiple support arms and methods for percutaneous heart valve replacement
US20120078356A1 (en) Percutaneously deliverable heart or blood vessel valve with frame having abluminally situated tissue membrane
JP2011509805A (en) Stent for prosthetic heart valve
WO2014110023A1 (en) Valve prosthesis
CN111110403A (en) Heart valve device with anchoring ring and using method thereof
CN107920862A (en) System and method for cardiac valves therapy
CN115212010B (en) An artificial heart valve
US20220008233A1 (en) Self-growing heart valves
CN212382790U (en) A heart valve device with an anchoring ring
JP2024160391A (en) HEART VALVE REPLACEMENT PROSTHESIS WITH ADVANTAGEOUS SEALING AND LOADING CHARACTERISTICS - Patent application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20090417

Address after: Room 401, room 19, Lane 828, North Ai Road, Shanghai, 200125

Applicant after: Wen Ning

Co-applicant after: Jin Lei

Address before: Room 401, room 19, Lane 828, North Ai Road, Shanghai, 200125

Applicant before: Wen Ning

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170831

Address after: 102200 Beijing City, Changping District science and Technology Park East China Chang Road No. 2

Patentee after: BEIJING BAIREN MEDICAL TECHNOLOGY

Address before: 200125, room 19, No. 828, Lane 401, North Ai Road, Shanghai

Co-patentee before: Jin Lei

Patentee before: Wen Ning

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170922

Address after: 102200 Beijing City, Changping District science and Technology Park East China Chang Road No. 2

Patentee after: BEIJING BAIREN MEDICAL TECHNOLOGY

Address before: 200125, room 19, No. 828, Lane 401, North Ai Road, Shanghai

Co-patentee before: Jin Lei

Patentee before: Wen Ning

CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 102200 Beijing City, Changping District science and Technology Park East China Chang Road No. 2

Patentee after: BEIJING BALANCE MEDICAL TECHNOLOGY Co.,Ltd.

Address before: 102200 Beijing City, Changping District science and Technology Park East China Chang Road No. 2

Patentee before: BEIJING BAIREN MEDICAL TECHNOLOGY

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20100127